<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:dcterms="http://purl.org/dc/terms/"
 xmlns:cc="http://web.resource.org/cc/"
 xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/"
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.mdpi.com/rss/journal/nutrients">
		<title>Nutrients</title>
		<link>http://www.mdpi.com/journal/nutrients</link>
		<description>Latest open access articles published in Nutrients at http://www.mdpi.com/journal/nutrients</description>
								<items>
			<rdf:Seq>
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/5/1823" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/5/1801" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/5/1757" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/5/1734" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/5/1719" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/5/1706" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/5/1672" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/5/1660" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/5/1648" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/5/1622" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/5/1609" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/5/1595" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/5/1585" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/5/1573" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/5/1561" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/5/1544" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/5/1531" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/5/1511" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/5/1500" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/5/1488" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/5/1471" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/4/1456" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/4/1436" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/4/1417" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/4/1384" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/4/1366" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/4/1349" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/4/1336" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/4/1316" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/4/1301" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/4/1287" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/4/1276" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/4/1253" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/4/1241" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/4/1218" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/4/1200" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/4/1186" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/4/1169" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/4/1149" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/4/1122" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/4/1110" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/4/1098" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/4/1081" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/4/1071" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/4/1058" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/4/1024" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/3/1002" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/3/981" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/3/971" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/3/957" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/3/949" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/3/928" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/3/915" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/3/887" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/3/877" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/3/852" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/3/829" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/3/811" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/3/788" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/3/771" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/3/758" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/3/750" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/3/725" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/3/711" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/3/700" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/3/679" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/3/663" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/3/651" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/3/637" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/3/624" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/2/608" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/2/594" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/2/579" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/2/565" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/2/552" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/2/543" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/2/525" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/2/509" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/2/498" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/2/478" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/2/468" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/2/455" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/2/441" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/2/424" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/2/411" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/2/396" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/2/388" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/2/359" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/2/340" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/2/328" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/1/302" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/1/283" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/1/267" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/1/253" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/1/234" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/1/223" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/1/208" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/1/162" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/1/149" />
            				<rdf:li rdf:resource="http://www.mdpi.com/2072-6643/5/1/111" />
                    	</rdf:Seq>
		</items>
				<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
	</channel>

        <item rdf:about="http://www.mdpi.com/2072-6643/5/5/1823">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1823-1839: The Role of Lutein in Eye-Related Disease]]></title>
	<link>http://www.mdpi.com/2072-6643/5/5/1823</link>
	<description>The lens and retina of the human eye are exposed constantly to light and oxygen. In situ phototransduction and oxidative phosphorylation within photoreceptors produces a high level of phototoxic and oxidative related stress. Within the eye, the carotenoids lutein and zeaxanthin are present in high concentrations in contrast to other human tissues. We discuss the role of lutein and zeaxanthin in ameliorating light and oxygen damage, and preventing age-related cellular and tissue deterioration in the eye. Epidemiologic research shows an inverse association between levels of lutein and zeaxanthin in eye tissues and age related degenerative diseases such as macular degeneration (AMD) and cataracts. We examine the role of these carotenoids as blockers of blue-light damage and quenchers of oxygen free radicals. This article provides a review of possible mechanisms of lutein action at a cellular and molecular level. Our review offers insight into current clinical trials and experimental animal studies involving lutein, and possible role of nutritional intervention in common ocular diseases that cause blindness.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-05-22</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5051823</prism:doi>
	<prism:startingPage>1823</prism:startingPage>
		<prism:endingPage>1839</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[The Role of Lutein in Eye-Related Disease]]></dc:title>
    <dc:date>2013-05-22</dc:date>
	<dc:identifier>doi: 10.3390/nu5051823</dc:identifier>
    	<dc:creator>Keyvan Koushan</dc:creator>
		<dc:creator>Raluca Rusovici</dc:creator>
		<dc:creator>Wenhua Li</dc:creator>
		<dc:creator>Lee Ferguson</dc:creator>
		<dc:creator>Kakarla Chalam</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/5/1801">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1801-1822: Dietary Fatty Acids and Immune Response to Food-Borne Bacterial Infections]]></title>
	<link>http://www.mdpi.com/2072-6643/5/5/1801</link>
	<description>Functional innate and acquired immune responses are required to protect the host from pathogenic bacterial infections. Modulation of host immune functions may have beneficial or deleterious effects on disease outcome. Different types of dietary fatty acids have been shown to have variable effects on bacterial clearance and disease outcome through suppression or activation of immune responses. Therefore, we have chosen to review research across experimental models and food sources on the effects of commonly consumed fatty acids on the most common food-borne pathogens, including Salmonella sp., Campylobacter sp., Shiga toxin-producing Escherichia coli, Shigella sp., Listeria monocytogenes, and Staphylococcus aureus. Altogether, the compilation of literature suggests that no single fatty acid is an answer for protection from all food-borne pathogens, and further research is necessary to determine the best approach to improve disease outcomes.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-05-22</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5051801</prism:doi>
	<prism:startingPage>1801</prism:startingPage>
		<prism:endingPage>1822</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Dietary Fatty Acids and Immune Response to Food-Borne Bacterial Infections]]></dc:title>
    <dc:date>2013-05-22</dc:date>
	<dc:identifier>doi: 10.3390/nu5051801</dc:identifier>
    	<dc:creator>Lisa Harrison</dc:creator>
		<dc:creator>Kannan Balan</dc:creator>
		<dc:creator>Uma Babu</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/5/1757">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1757-1800: Can Scientific Evidence Support Using Bangladeshi Traditional Medicinal Plants in the Treatment of Diarrhoea? A Review on Seven Plants]]></title>
	<link>http://www.mdpi.com/2072-6643/5/5/1757</link>
	<description>Diarrhoea is a common disease which causes pain and may be deadly, especially in developing countries. In Bangladesh, diarrhoeal diseases affect thousands of people every year, and children are especially vulnerable. Bacterial toxins or viral infections are the most common cause of the disease. The diarrhoea outbreaks are often associated with flood affected areas with contaminated drinking water and an increased risk of spreading the water-borne disease. Not surprisingly, plants found in the near surroundings have been taken into use by the local community as medicine to treat diarrhoeal symptoms. These plants are cheaper and more easily available than conventional medicine. Our question is: What is the level of documentation supporting the use of these plants against diarrhoea and is their consumption safe? Do any of these plants have potential for further exploration? In this review, we have choosen seven plant species that are used in the treatment of diarrhoea; Diospyros peregrina, Heritiera littoralis, Ixora coccinea, Pongamia pinnata, Rhizophora mucronata, Xylocarpus granatum, and Xylocarpus moluccensis. Appearance and geographical distribution, traditional uses, chemical composition, and biological studies related to antidiarrhoeal activity will be presented. This review reveals that there is limited scientific evidence supporting the traditional use of these plants. Most promising are the barks from D. peregrina, X. granatum and X. moluccensis which contain tannins and have shown promising results in antidiarrhoeal mice models. The leaves of P. pinnata also show potential. We suggest these plants should be exploited further as possible traditional herbal remedies against diarrhoea including studies on efficacy, optimal dosage and safety.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-05-22</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5051757</prism:doi>
	<prism:startingPage>1757</prism:startingPage>
		<prism:endingPage>1800</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Can Scientific Evidence Support Using Bangladeshi Traditional Medicinal Plants in the Treatment of Diarrhoea? A Review on Seven Plants]]></dc:title>
    <dc:date>2013-05-22</dc:date>
	<dc:identifier>doi: 10.3390/nu5051757</dc:identifier>
    	<dc:creator>Helle Wangensteen</dc:creator>
		<dc:creator>Line Klarpås</dc:creator>
		<dc:creator>Mahiuddin Alamgir</dc:creator>
		<dc:creator>Anne Samuelsen</dc:creator>
		<dc:creator>Karl Malterud</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/5/1734">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1734-1756: Selenium Metabolism in Cancer Cells: The Combined Application of XAS and XFM Techniques to the Problem of Selenium Speciation in Biological Systems]]></title>
	<link>http://www.mdpi.com/2072-6643/5/5/1734</link>
	<description>Determining the speciation of selenium in vivo is crucial to understanding the biological activity of this essential element, which is a popular dietary supplement due to its anti-cancer properties. Hyphenated techniques that combine separation and detection methods are traditionally and effectively used in selenium speciation analysis, but require extensive sample preparation that may affect speciation. Synchrotron-based X-ray absorption and fluorescence techniques offer an alternative approach to selenium speciation analysis that requires minimal sample preparation. We present a brief summary of some key HPLC-ICP-MS and ESI-MS/MS studies of the speciation of selenium in cells and rat tissues. We review the results of a top-down approach to selenium speciation in human lung cancer cells that aims to link the speciation and distribution of selenium to its biological activity using a combination of X-ray absorption spectroscopy (XAS) and X-ray fluorescence microscopy (XFM). The results of this approach highlight the distinct fates of selenomethionine, methylselenocysteine and selenite in terms of their speciation and distribution within cells: organic selenium metabolites were widely distributed throughout the cells, whereas inorganic selenium metabolites were compartmentalized and associated with copper. New data from the XFM mapping of electrophoretically-separated cell lysates show the distribution of selenium in the proteins of selenomethionine-treated cells. Future applications of this top-down approach are discussed.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-05-21</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5051734</prism:doi>
	<prism:startingPage>1734</prism:startingPage>
		<prism:endingPage>1756</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Selenium Metabolism in Cancer Cells: The Combined Application of XAS and XFM Techniques to the Problem of Selenium Speciation in Biological Systems]]></dc:title>
    <dc:date>2013-05-21</dc:date>
	<dc:identifier>doi: 10.3390/nu5051734</dc:identifier>
    	<dc:creator>Claire Weekley</dc:creator>
		<dc:creator>Jade Aitken</dc:creator>
		<dc:creator>Lydia Finney</dc:creator>
		<dc:creator>Stefan Vogt</dc:creator>
		<dc:creator>Paul Witting</dc:creator>
		<dc:creator>Hugh Harris</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/5/1719">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1719-1733: A Diet Pattern with More Dairy and Nuts, but Less Meat Is Related to Lower Risk of Developing Hypertension in Middle-Aged Adults: The Atherosclerosis Risk in Communities (ARIC) Study]]></title>
	<link>http://www.mdpi.com/2072-6643/5/5/1719</link>
	<description>Dietary intake among other lifestyle factors influence blood pressure. We examined the associations of an ―a priori‖ diet score with incident high normal blood pressure (HNBP; systolic blood pressure (SBP) 120–139 mmHg, or diastolic blood pressure (DBP) 80–89 mmHg and no antihypertensive medications) and hypertension (SBP ≥ 140 mmHg, DBP ≥ 90 mmHg, or taking antihypertensive medication). We used proportional hazards regression to evaluate this score in quintiles (Q) and each food group making up the score relative to incident HNBP or hypertension over nine years in the Atherosclerosis Risk of Communities (ARIC) study of 9913 African-American and Caucasian adults aged 45–64 years and free of HNBP or hypertension at baseline. Incidence of HNBP varied from 42.5% in white women to 44.1% in black women; and incident hypertension from 26.1% in white women to 40.8% in black women. Adjusting for demographics and CVD risk factors, the ―a priori‖ food score was inversely associated with incident hypertension; but not HNBP. Compared to Q1, the relative hazards of hypertension for the food score Q2–Q5 were 0.97 (0.87–1.09), 0.91 (0.81–1.02), 0.91 (0.80–1.03), and 0.86 (0.75–0.98); ptrend = 0.01. This inverse relation was largely attributable to greater intake of dairy products and nuts, and less meat. These findings support the 2010 Dietary Guidelines to consume more dairy products and nuts, but suggest a reduction in meat intake.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-05-21</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5051719</prism:doi>
	<prism:startingPage>1719</prism:startingPage>
		<prism:endingPage>1733</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[A Diet Pattern with More Dairy and Nuts, but Less Meat Is Related to Lower Risk of Developing Hypertension in Middle-Aged Adults: The Atherosclerosis Risk in Communities (ARIC) Study]]></dc:title>
    <dc:date>2013-05-21</dc:date>
	<dc:identifier>doi: 10.3390/nu5051719</dc:identifier>
    	<dc:creator>Lu-Chen Weng</dc:creator>
		<dc:creator>Lyn Steffen</dc:creator>
		<dc:creator>Moyses Szklo</dc:creator>
		<dc:creator>Jennifer Nettleton</dc:creator>
		<dc:creator>Lloyd Chambless</dc:creator>
		<dc:creator>Aaron Folsom</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/5/1706">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1706-1718: Genome-Wide Association Study of Serum Selenium Concentrations]]></title>
	<link>http://www.mdpi.com/2072-6643/5/5/1706</link>
	<description>Selenium is an essential trace element and circulating selenium concentrations have been associated with a wide range of diseases. Candidate gene studies suggest that circulating selenium concentrations may be impacted by genetic variation; however, no study has comprehensively investigated this hypothesis. Therefore, we conducted a two-stage genome-wide association study to identify genetic variants associated with serum selenium concentrations in 1203 European descents from two cohorts: the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening and the Women’s Health Initiative (WHI). We tested association between 2,474,333 single nucleotide polymorphisms (SNPs) and serum selenium concentrations using linear regression models. In the first stage (PLCO) 41 SNPs clustered in 15 regions had p &amp;amp;lt; 1 × 10−5. None of these 41 SNPs reached the significant threshold (p = 0.05/15 regions = 0.003) in the second stage (WHI). Three SNPs had p &amp;amp;lt; 0.05 in the second stage (rs1395479 and rs1506807 in 4q34.3/AGA-NEIL3; and rs891684 in 17q24.3/SLC39A11) and had p between 2.62 × 10−7 and 4.04 × 10−7 in the combined analysis (PLCO + WHI). Additional studies are needed to replicate these findings. Identification of genetic variation that impacts selenium concentrations may contribute to a better understanding of which genes regulate circulating selenium concentrations.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-05-21</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5051706</prism:doi>
	<prism:startingPage>1706</prism:startingPage>
		<prism:endingPage>1718</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Genome-Wide Association Study of Serum Selenium Concentrations]]></dc:title>
    <dc:date>2013-05-21</dc:date>
	<dc:identifier>doi: 10.3390/nu5051706</dc:identifier>
    	<dc:creator>Jian Gong</dc:creator>
		<dc:creator>Li Hsu</dc:creator>
		<dc:creator>Tabitha Harrison</dc:creator>
		<dc:creator>Irena King</dc:creator>
		<dc:creator>Stefan Stürup</dc:creator>
		<dc:creator>Xiaoling Song</dc:creator>
		<dc:creator>David Duggan</dc:creator>
		<dc:creator>Yan Liu</dc:creator>
		<dc:creator>Carolyn Hutter</dc:creator>
		<dc:creator>Stephen Chanock</dc:creator>
		<dc:creator>Charles Eaton</dc:creator>
		<dc:creator>James Marshall</dc:creator>
		<dc:creator>Ulrike Peters</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/5/1672">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1672-1705: The Relationship between Dietary Fatty Acids and Inflammatory Genes on the Obese Phenotype and Serum Lipids]]></title>
	<link>http://www.mdpi.com/2072-6643/5/5/1672</link>
	<description>Obesity, a chronic low-grade inflammatory condition is associated with the development of many comorbidities including dyslipidemia. This review examines interactions between single nucleotide polymorphisms (SNP) in the inflammatory genes tumor necrosis alpha (TNFA) and interleukin-6 (IL-6) and dietary fatty acids, and their relationship with obesity and serum lipid levels. In summary, dietary fatty acids, in particular saturated fatty acids and the omega-3 and omega-6 polyunsaturated fatty acids, impact the expression of the cytokine genes TNFA and IL-6, and alter TNFα and IL-6 production. In addition, sequence variants in these genes have also been shown to alter their gene expression and plasma levels, and are associated with obesity, measures of adiposity and serum lipid concentrations. When interactions between dietary fatty acids and TNFA and IL-6 SNPs on obesity and serum lipid were analyzed, both the quantity and quality of dietary fatty acids modulated the relationship between TNFA and IL-6 SNPs on obesity and serum lipid profiles, thereby impacting the association between phenotype and genotype. Researching these diet–gene interactions more extensively, and understanding the role of ethnicity as a confounder in these relationships, may contribute to a better understanding of the inter-individual variability in the obese phenotype.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-05-21</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5051672</prism:doi>
	<prism:startingPage>1672</prism:startingPage>
		<prism:endingPage>1705</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[The Relationship between Dietary Fatty Acids and Inflammatory Genes on the Obese Phenotype and Serum Lipids]]></dc:title>
    <dc:date>2013-05-21</dc:date>
	<dc:identifier>doi: 10.3390/nu5051672</dc:identifier>
    	<dc:creator>Yael Joffe</dc:creator>
		<dc:creator>Malcolm Collins</dc:creator>
		<dc:creator>Julia Goedecke</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/5/1660">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1660-1671: Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Uncoupling Protein 3 Gene Expression in C2C12 Muscle Cells]]></title>
	<link>http://www.mdpi.com/2072-6643/5/5/1660</link>
	<description>Uncoupling protein 3 (UCP3) is a mitochondrial membrane transporter that is expressed mainly in skeletal muscle where it plays an important role in energy expenditure and fat oxidation. In this study, we investigated the effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on UCP3 gene expression in C2C12 muscle cells. EPA and DHA up-regulated UCP3 mRNA level in a dose-dependent manner and similarly increased UCP3 promoter activity in C2C12 muscle cells. To determine whether  AMP-activated protein kinase (AMPK) signaling may also directly regulate UCP3 expression, 5′-amino-4-imidazolecarboxamide-ribonucleoside (AICAR), an AMP analog that activates AMPK, was treated in C2C12 muscle cells. AICAR showed additive effects with EPA or DHA on the UCP3 promoter activation. These results indicate that EPA and DHA directly regulate the gene expression of UCP3, potentially through AMPK-mediated pathway in C2C12 muscle cells.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-05-21</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5051660</prism:doi>
	<prism:startingPage>1660</prism:startingPage>
		<prism:endingPage>1671</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Uncoupling Protein 3 Gene Expression in C2C12 Muscle Cells]]></dc:title>
    <dc:date>2013-05-21</dc:date>
	<dc:identifier>doi: 10.3390/nu5051660</dc:identifier>
    	<dc:creator>Mak-Soon Lee</dc:creator>
		<dc:creator>In-Hwan Kim</dc:creator>
		<dc:creator>Yangha Kim</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/5/1648">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1648-1659: Inhibitory Effects and Mechanisms of Luteolin on Proliferation and Migration of Vascular Smooth Muscle Cells]]></title>
	<link>http://www.mdpi.com/2072-6643/5/5/1648</link>
	<description>Atherosclerosis is a complicated progress, involving many types of cells. Although the exact mechanisms of progression of atherosclerosis are uncertain, the balance of vascular smooth muscle cells (VSMCs) proliferation and apoptosis appears to play a pivotal role in the pathogenesis and progression of atherosclerosis, and much discussion has been undertaken to elucidate the detailed mechanisms, relevant gene expression and transduction pathways. Drug treatment has focused on ameliorating atherosclerosis. Some researchers have indicated that inhibiting VSMCs proliferation is involved in attenuating atherosclerosis. Luteolin is a kind of flavonoids naturally occurring in many plants and possesses beneficial effects on cardiovascular diseases. Luteolin can reduce VSMCs’ proliferation and migration and this reduction is stimulated by several factors. The aim of this review is to summarize the existing inhibitory effects and mechanisms of luteolin on proliferation and migration of VSMCs, and consider whether luteolin may be a potential candidate for preventing and treating atherosclerosis.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-05-17</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5051648</prism:doi>
	<prism:startingPage>1648</prism:startingPage>
		<prism:endingPage>1659</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Inhibitory Effects and Mechanisms of Luteolin on Proliferation and Migration of Vascular Smooth Muscle Cells]]></dc:title>
    <dc:date>2013-05-17</dc:date>
	<dc:identifier>doi: 10.3390/nu5051648</dc:identifier>
    	<dc:creator>Dehua Jiang</dc:creator>
		<dc:creator>Dongye Li</dc:creator>
		<dc:creator>Wanling Wu</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/5/1622">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1622-1647: Iron Absorption in Drosophila melanogaster]]></title>
	<link>http://www.mdpi.com/2072-6643/5/5/1622</link>
	<description>The way in which Drosophila melanogaster acquires iron from the diet remains poorly understood despite iron absorption being of vital significance for larval growth.  To describe the process of organismal iron absorption, consideration needs to be given to cellular iron import, storage, export and how intestinal epithelial cells sense and respond to iron availability. Here we review studies on the Divalent Metal Transporter-1 homolog Malvolio (iron import), the recent discovery that Multicopper Oxidase-1 has ferroxidase activity (iron export) and the role of ferritin in the process of iron acquisition  (iron storage). We also describe what is known about iron regulation in insect cells.  We then draw upon knowledge from mammalian iron homeostasis to identify candidate genes in flies. Questions arise from the lack of conservation in Drosophila for key  mammalian players, such as ferroportin, hepcidin and all the components of the  hemochromatosis-related pathway. Drosophila and other insects also lack erythropoiesis. Thus, systemic iron regulation is likely to be conveyed by different signaling pathways and tissue requirements. The significance of regulating intestinal iron uptake is inferred from reports linking Drosophila developmental, immune, heat-shock and behavioral responses to iron sequestration.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-05-17</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5051622</prism:doi>
	<prism:startingPage>1622</prism:startingPage>
		<prism:endingPage>1647</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Iron Absorption in Drosophila melanogaster]]></dc:title>
    <dc:date>2013-05-17</dc:date>
	<dc:identifier>doi: 10.3390/nu5051622</dc:identifier>
    	<dc:creator>Konstantinos Mandilaras</dc:creator>
		<dc:creator>Tharse Pathmanathan</dc:creator>
		<dc:creator>Fanis Missirlis</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/5/1609">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1609-1621: Sources of Vitamin A in the Diets of Pre-School Children in the Avon Longitudinal Study of Parents and Children (ALSPAC)]]></title>
	<link>http://www.mdpi.com/2072-6643/5/5/1609</link>
	<description>Vitamin A is essential for growth and development. We investigated whether high consumption of energy-dense nutrient-poor foods in the diets of pre-school children is detrimental to diet quality with respect to vitamin A. Data were collected from  755 children at 18-months and 3½-years, from the Avon Longitudinal Study of Parents and Children, using 3-day unweighed dietary records completed by parents in 1994 and 1996, respectively. Energy, carotene and retinol intakes were calculated. The quality of the diet declined from 18-months to 3½-years with respect to vitamin A. Preformed retinol intakes decreased by −54 μg/day on average (p = 0.003). Carotene intakes were similar at each age although there was a 23% increase in energy intake by 3½-years. Longitudinally those in the highest quartile of intake at 18-months were twice as likely to remain in the highest quartile at 3½-years for retinol (OR 2.21 (95% CI 1.48–3.28)) and carotene (OR 1.66  (95% CI 1.11–2.50)) than to change quartiles. Nutrient-rich core foods provided decreasing amounts of carotene and preformed retinol over time (both p &amp;amp;lt; 0.001). Vegetables and milk contributed the highest proportion of carotene at both ages, but milk’s contribution decreased over time. Milk and liver were the largest sources of retinol. Nutrient-poor foods provided an increased proportion of energy (p &amp;amp;lt; 0.001) with low proportions of both nutrients; however fat spreads made an important contribution. It is recommended that  pre-school children should take vitamin supplements; only 19% at 18-months did this, falling to 11% at 3½-years. Care should be taken to choose nutrient-rich foods and avoid energy-dense, nutrient-poor foods when feeding pre-school children.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-05-15</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5051609</prism:doi>
	<prism:startingPage>1609</prism:startingPage>
		<prism:endingPage>1621</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Sources of Vitamin A in the Diets of Pre-School Children in the Avon Longitudinal Study of Parents and Children (ALSPAC)]]></dc:title>
    <dc:date>2013-05-15</dc:date>
	<dc:identifier>doi: 10.3390/nu5051609</dc:identifier>
    	<dc:creator>Victoria Cribb</dc:creator>
		<dc:creator>Kate Northstone</dc:creator>
		<dc:creator>David Hopkins</dc:creator>
		<dc:creator>Pauline Emmett</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/5/1595">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1595-1608: Iron Deficiency and Bariatric Surgery]]></title>
	<link>http://www.mdpi.com/2072-6643/5/5/1595</link>
	<description>It is estimated that the prevalence of anaemia in patients scheduled for bariatric surgery is higher than in the general population and the prevalence of iron deficiencies (with or without anaemia) may be higher as well. After surgery, iron deficiencies and anaemia may occur in a higher percentage of patients, mainly as a consequence of nutrient deficiencies. In addition, perioperative anaemia has been related with increased postoperative morbidity and mortality and poorer quality of life after bariatric surgery. The treatment of perioperative anaemia and nutrient deficiencies has been shown to improve patients’ outcomes and quality of life. All patients should undergo an appropriate nutritional evaluation, including selective micronutrient measurements (e.g., iron), before any bariatric surgical procedure. In comparison with purely restrictive procedures, more extensive perioperative nutritional evaluations are required for malabsorptive procedures due to their nutritional consequences. The aim of this study was to review the current knowledge of nutritional deficits in obese patients and those that commonly appear after bariatric surgery, specifically iron deficiencies and their consequences. As a result, some recommendations for screening and supplementation are presented.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-05-15</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5051595</prism:doi>
	<prism:startingPage>1595</prism:startingPage>
		<prism:endingPage>1608</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Iron Deficiency and Bariatric Surgery]]></dc:title>
    <dc:date>2013-05-15</dc:date>
	<dc:identifier>doi: 10.3390/nu5051595</dc:identifier>
    	<dc:creator>Ignacio Jáuregui-Lobera</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/5/1585">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1585-1594: Is Dietitian Use Associated with Celiac Disease Outcomes?]]></title>
	<link>http://www.mdpi.com/2072-6643/5/5/1585</link>
	<description>A gluten-free diet (GFD) is the treatment for celiac disease (CD), but due to its complexity, dietitian referral is uniformly recommended. We surveyed patients with CD to determine if dietitian use is associated with quality of life, symptom severity, or GFD adherence. The survey utilized three validated CD-specific instruments: the CD quality of life (CD-QOL), CD symptom index (CSI) and CD adherence test (CDAT). Four hundred and thirteen patients with biopsy-proven CD were eligible for inclusion. The majority (77%) were female and mean BMI was 24.1. Over three-quarters of patients (326, 79%) had seen a dietitian, however, 161 (39%) had seen a dietitian only once. Age, sex, and education level were not associated with dietitian use; nor was BMI (24.6 vs. 24.0,  p = 0.45). On multivariate analysis, adjusting for age gender, education, duration of disease, and body mass index, dietitian use was not associated with CD-QOL, CSI, or CDAT scores. Our survey did not show an association between dietitian use and symptom severity, adherence, or quality of life. Delay in diagnosis was associated with poorer outcomes. This is a preliminary study with several limitations, and further prospective analysis is needed to evaluate the benefits and cost-effectiveness of dietitian-referral in the care of celiac disease patients.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-05-15</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5051585</prism:doi>
	<prism:startingPage>1585</prism:startingPage>
		<prism:endingPage>1594</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Is Dietitian Use Associated with Celiac Disease Outcomes?]]></dc:title>
    <dc:date>2013-05-15</dc:date>
	<dc:identifier>doi: 10.3390/nu5051585</dc:identifier>
    	<dc:creator>SriHari Mahadev</dc:creator>
		<dc:creator>Suzanne Simpson</dc:creator>
		<dc:creator>Benjamin Lebwohl</dc:creator>
		<dc:creator>Suzanne Lewis</dc:creator>
		<dc:creator>Christina Tennyson</dc:creator>
		<dc:creator>Peter Green</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/5/1573">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1573-1584: Chocolate in History: Food, Medicine, Medi-Food]]></title>
	<link>http://www.mdpi.com/2072-6643/5/5/1573</link>
	<description>Throughout history, chocolate has been used to treat a wide variety of ailments, and in recent years, multiple studies have found that chocolate can have positive health effects, providing evidence to a centuries-long established use; this acknowledgement, however, did not have a straight course, having been involved in religious, medical and cultural controversies. Christian Europe, in fact, feared the exhilarating effects of new drinks, such as chocolate, coffee and tea. Therefore, these beverages would have been banished, had not doctors and scientists explained that they were good for the body. The scientific debate, which reached its peak in Florence in the 18th century, regarded the therapeutic effectiveness of the various chocolate components: it was necessary to know their properties first, in order to prepare the best cacao concoction for every patient. When Dietetics separated from Medicine, however, chocolate acquired the role of vehicle for easing the administration of bitter medicines, being associated to different health problems. The recent rediscovery of the beneficial use of cacao and chocolate focuses upon its value as supplemental nutrition. Building a bridge to the past may be helpful to detect the areas where the potential health benefits of chocolate are likely to be further explored.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-05-14</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Introduction</prism:section>
	<prism:doi>10.3390/nu5051573</prism:doi>
	<prism:startingPage>1573</prism:startingPage>
		<prism:endingPage>1584</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Chocolate in History: Food, Medicine, Medi-Food]]></dc:title>
    <dc:date>2013-05-14</dc:date>
	<dc:identifier>doi: 10.3390/nu5051573</dc:identifier>
    	<dc:creator>Donatella Lippi</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/5/1561">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1561-1572: Vitamin D Insufficiency and Bone Mineral Status in a Population of Newcomer Children in Canada]]></title>
	<link>http://www.mdpi.com/2072-6643/5/5/1561</link>
	<description>Background: Low levels of circulating vitamin D are more likely to be found in those with darker skin pigmentation, who live in areas of high latitude, and who wear more clothing. We examined the prevalence of vitamin D deficiency and inadequacy in newcomer immigrant and refugee children. Methods: We evaluated circulating vitamin D status of immigrant children at the national level. Subsequently, we investigated vitamin D intake, circulating vitamin D status, and total body bone mineral content (TBBMC) in newcomer children living in Saskatchewan. Results: In the sample of newcomer children in Saskatchewan, the prevalence of inadequacy in calcium and vitamin D intakes was 76% and 89.4%, respectively. Vitamin D intake from food/supplement was significantly higher in immigrants compared to refugees, which accords with the significant difference in serum status. Circulating vitamin D status indicated that 29% of participants were deficient and another 44% had inadequate levels of serum 25(OH)D for bone health. Dietary vitamin D intake, sex, region of origin, and length of stay in Canada were significant predictors of serum vitamin D status. Results for TBBMC revealed that 38.6% were found to have low TBBMC compared to estimated values for age, sex, and ethnicity. In the regression model, after controlling for possible confounders, children who were taller and had greater  circulating vitamin D also had greater TBBMC. Nationally, immigrant children, particularly girls, have significantly lower plasma 25(OH)D than non-immigrant children. Interpretation: Newcomer immigrant and refugee children are at a high risk of vitamin D deficiency and inadequacy, which may have serious negative consequences for their health.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-05-14</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5051561</prism:doi>
	<prism:startingPage>1561</prism:startingPage>
		<prism:endingPage>1572</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Vitamin D Insufficiency and Bone Mineral Status in a Population of Newcomer Children in Canada]]></dc:title>
    <dc:date>2013-05-14</dc:date>
	<dc:identifier>doi: 10.3390/nu5051561</dc:identifier>
    	<dc:creator>Hassanali Vatanparast</dc:creator>
		<dc:creator>Christine Nisbet</dc:creator>
		<dc:creator>Brian Gushulak</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/5/1544">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1544-1560: Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease]]></title>
	<link>http://www.mdpi.com/2072-6643/5/5/1544</link>
	<description>Non-alcoholic fatty liver disease is marked by hepatic fat accumulation not due to alcohol abuse. Several studies have demonstrated that NAFLD is associated with insulin resistance leading to a resistance in the antilipolytic effect of insulin in the adipose tissue with an increase of free fatty acids (FFAs). The increase of FFAs induces mitochondrial dysfunction and development of lipotoxicity. Moreover, in subjects with NAFLD, ectopic fat also accumulates as cardiac and pancreatic fat. In this review we analyzed the mechanisms that relate NAFLD with metabolic syndrome and dyslipidemia and its association with the development and progression of cardiovascular disease.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-05-10</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5051544</prism:doi>
	<prism:startingPage>1544</prism:startingPage>
		<prism:endingPage>1560</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease]]></dc:title>
    <dc:date>2013-05-10</dc:date>
	<dc:identifier>doi: 10.3390/nu5051544</dc:identifier>
    	<dc:creator>Melania Gaggini</dc:creator>
		<dc:creator>Mariangela Morelli</dc:creator>
		<dc:creator>Emma Buzzigoli</dc:creator>
		<dc:creator>Ralph DeFronzo</dc:creator>
		<dc:creator>Elisabetta Bugianesi</dc:creator>
		<dc:creator>Amalia Gastaldelli</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/5/1531">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1531-1543: Homocysteine Lowering by Folate-Rich Diet or  Pharmacological Supplementations in Subjects with  Moderate Hyperhomocysteinemia]]></title>
	<link>http://www.mdpi.com/2072-6643/5/5/1531</link>
	<description>To compare the efficacy of a diet rich in natural  folate and of two different folic acid supplementation protocols in subjects with “moderate” hyperhomocysteinemia, also taking into account C677T polymorphism of  5,10-methylenetetrahydrofolate reductase (MTHFR) gene. Subjects/Methods: We performed a 13 week open, randomized, double blind clinical trial on 149 free living persons with mild hyperhomocyteinemia, with daily 200 μg from a natural folate-rich diet, 200 μg [6S]5-methyltetrahydrofolate (5-MTHF), 200 μg folic acid or placebo. Participants were stratified according to their MTHFR genotype. Results: Homocysteine (Hcy) levels were reduced after folate enriched diet, 5-MTHF or folic acid supplementation respectively by 20.1% (p &amp;amp;lt; 0.002), 19.4% (p &amp;amp;lt; 0.001) and 21.9% (p &amp;amp;lt; 0.001), as compared to baseline levels and significantly as compared to placebo (p &amp;amp;lt; 0.001, p &amp;amp;lt; 0.002 and p &amp;amp;lt; 0.001, respectively for enriched diet, 5-MTHF and folic acid). After this enriched diet and the folic acid supplementation, Hcy in both genotype groups decreased approximately to the same level, with higher percentage decreases observed for the TT group because of their higher pre-treatment value. Similar results were not seen by genotype for 5-MTHF. A significant increase in RBC folate concentration was observed after folic acid and natural folate-rich food supplementations, as compared to placebo. Conclusions: Supplementation with natural folate-rich foods, folic acid and 5-MTHF reached a similar reduction in  Hcy concentrations.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-05-08</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5051531</prism:doi>
	<prism:startingPage>1531</prism:startingPage>
		<prism:endingPage>1543</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Homocysteine Lowering by Folate-Rich Diet or  Pharmacological Supplementations in Subjects with  Moderate Hyperhomocysteinemia]]></dc:title>
    <dc:date>2013-05-08</dc:date>
	<dc:identifier>doi: 10.3390/nu5051531</dc:identifier>
    	<dc:creator>Bruno Zappacosta</dc:creator>
		<dc:creator>Pierpaolo Mastroiacovo</dc:creator>
		<dc:creator>Silvia Persichilli</dc:creator>
		<dc:creator>George Pounis</dc:creator>
		<dc:creator>Stefania Ruggeri</dc:creator>
		<dc:creator>Angelo Minucci</dc:creator>
		<dc:creator>Emilia Carnovale</dc:creator>
		<dc:creator>Generoso Andria</dc:creator>
		<dc:creator>Roberta Ricci</dc:creator>
		<dc:creator>Iris Scala</dc:creator>
		<dc:creator>Orazio Genovese</dc:creator>
		<dc:creator>Aida Turrini</dc:creator>
		<dc:creator>Lorenza Mistura</dc:creator>
		<dc:creator>Bruno Giardina</dc:creator>
		<dc:creator>Licia Iacoviello</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/5/1511">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1511-1530: Dietary Patterns in Pregnancy and Effects on Nutrient Intake in the Mid-South: The Conditions Affecting Neurocognitive Development and Learning in Early Childhood (CANDLE) Study]]></title>
	<link>http://www.mdpi.com/2072-6643/5/5/1511</link>
	<description>Dietary patterns are sensitive to differences across socio-economic strata or cultural habits and may impact programing of diseases in later life. The purpose of this study was to identify distinct dietary patterns during pregnancy in the Mid-South using factor analysis. Furthermore, we aimed to analyze the differences in the food groups and in macro- and micronutrients among the different food patterns. The study was a cross-sectional analysis of 1155 pregnant women (mean age 26.5 ± 5.4 years; 62% African American, 35% Caucasian, 3% Other; and pre-pregnancy BMI 27.6 ± 7.5 kg/m2). Using food frequency questionnaire data collected from participants in the Conditions Affecting Neurocognitive Development and Learning in Early Childhood (CANDLE) study between 16 and 28 weeks of gestation, dietary patterns were identified using factor analysis. Three major dietary patterns, namely, Healthy, Processed, and US Southern were identified among pregnant women from the Mid-South. Further analysis of the three main patterns revealed four mixed dietary patterns, i.e., Healthy-Processed, Healthy-US Southern, Processed-US Southern, and overall Mixed. These dietary patterns were different (p &amp;amp;lt; 0.001) from each other in almost all the food items, macro- and micro nutrients and aligned across socioeconomic and racial groups. Our study describes unique dietary patterns in the  Mid-South, consumed by a cohort of women enrolled in a prospective study examining the association of maternal nutritional factors during pregnancy that are known to affect brain and cognitive development by age 3.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-05-03</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5051511</prism:doi>
	<prism:startingPage>1511</prism:startingPage>
		<prism:endingPage>1530</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Dietary Patterns in Pregnancy and Effects on Nutrient Intake in the Mid-South: The Conditions Affecting Neurocognitive Development and Learning in Early Childhood (CANDLE) Study]]></dc:title>
    <dc:date>2013-05-03</dc:date>
	<dc:identifier>doi: 10.3390/nu5051511</dc:identifier>
    	<dc:creator>Eszter Völgyi</dc:creator>
		<dc:creator>Kecia Carroll</dc:creator>
		<dc:creator>Marion Hare</dc:creator>
		<dc:creator>Karen Ringwald-Smith</dc:creator>
		<dc:creator>Chandrika Piyathilake</dc:creator>
		<dc:creator>Wonsuk Yoo</dc:creator>
		<dc:creator>Frances Tylavsky</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/5/1500">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1500-1510: Fermentation Profiles of Wheat Dextrin, Inulin and Partially Hydrolyzed Guar Gum Using an in Vitro Digestion Pretreatment and in Vitro Batch Fermentation System Model]]></title>
	<link>http://www.mdpi.com/2072-6643/5/5/1500</link>
	<description>This study investigated the fermentation and microbiota profiles of three fibers, wheat dextrin (WD), partially hydrolyzed guar gum (PHGG), and inulin, since little is known about the effects of WD and PHGG on gut microbiota. A treatment of salivary amylase, pepsin, and pancreatin was used to better physiologic digestion. Fibers (0.5 g) were fermented in triplicate including a control group without fiber for 0, 4, 8, 12, and 24 h. Analysis of pH, gas volume, hydrogen and methane gases, and short chain fatty acid (SCFA) concentrations were completed at each time point. Quantitative polymerase chain reaction (qPCR) was used to measure Bifidobacteria and Lactobacillus CFUs at 24 h. WD produced the least gas during fermentation at 8, 12, and 24 h (P &amp;amp;lt; 0.0001), while inulin produced the most by 8 h (P &amp;amp;lt; 0.0001). Each fiber reached its lowest pH value at different time points with inulin at 8 h (mean ± SE) (5.94 ± 0.03), PHGG at 12 h (5.98 ± 0.01), and WD at 24 h (6.17 ± 0.03). All fibers had higher total SCFA concentrations compared to the negative control (P &amp;amp;lt; 0.05) at 24 h. At 24 h, inulin produced significantly (P = 0.0016) more butyrate than WD with PHGG being similar to both. An exploratory microbial analysis (log10 CFU/µL) showed WD had CFU for Bifidobacteria (6.12) and Lactobacillus (7.15) compared with the control (4.92 and 6.35, respectively). Rate of gas production is influenced by fiber source and may affect tolerance in vivo. Exploratory microbiota data hint at high levels of Bifidobacteria for WD, but require more robust investigation to corroborate these findings.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-05-03</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5051500</prism:doi>
	<prism:startingPage>1500</prism:startingPage>
		<prism:endingPage>1510</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Fermentation Profiles of Wheat Dextrin, Inulin and Partially Hydrolyzed Guar Gum Using an in Vitro Digestion Pretreatment and in Vitro Batch Fermentation System Model]]></dc:title>
    <dc:date>2013-05-03</dc:date>
	<dc:identifier>doi: 10.3390/nu5051500</dc:identifier>
    	<dc:creator>Jackie Noack</dc:creator>
		<dc:creator>Derek Timm</dc:creator>
		<dc:creator>Ashok Hospattankar</dc:creator>
		<dc:creator>Joanne Slavin</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/5/1488">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1488-1499: Interaction between Host Cells and Microbes  in Chemotherapy-Induced Mucositis]]></title>
	<link>http://www.mdpi.com/2072-6643/5/5/1488</link>
	<description>Cancer patients receiving chemotherapy often develop mucositis as a direct result of their treatment. Recently, the intestinal microbiota has attracted significant attention in the investigation of the pathobiology of mucositis, with a number of studies investigating the effects of chemotherapeutic agents on the microbiota. With significant effects on the intestinal microbiota occurring following the administration of chemotherapy, there is now interest surrounding the downstream pathological effects that may be associated with the altered intestinal ecology. This review seeks to identify links between signalling pathways previously demonstrated to have a role in the development of mucositis, and the altered intestinal microbiota.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-04-29</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5051488</prism:doi>
	<prism:startingPage>1488</prism:startingPage>
		<prism:endingPage>1499</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Interaction between Host Cells and Microbes  in Chemotherapy-Induced Mucositis]]></dc:title>
    <dc:date>2013-04-29</dc:date>
	<dc:identifier>doi: 10.3390/nu5051488</dc:identifier>
    	<dc:creator>Andrea Stringer</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/5/1471">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1471-1487: Major Cereal Grain Fibers and Psyllium in Relation to Cardiovascular Health]]></title>
	<link>http://www.mdpi.com/2072-6643/5/5/1471</link>
	<description>Numerous studies reveal the cardiovascular benefits of consuming dietary fiber and, especially, cereal fiber. Cereal fiber is associated with cardiovascular risk reduction through multiple mechanisms and consuming a variety of cereal fiber sources offers health benefits specific to the source. Certain cereal fibers have been studied more extensively than others and provide greater support for their incorporation into a healthful diet.  β-glucan from oats or barley, or a combination of whole oats and barley, and soluble fiber from psyllium reduces the risk of coronary heart disease; inulin-type fructans added to foods and beverages may modestly decrease serum triacylglycerols; arabinoxylan and resistant starch may improve glycemic control. Individuals with low cereal fiber intake should increase their intake of whole grains in order to receive the benefits of whole grains in addition to fiber. For those adjusting to the texture and palatability of whole grains, turning to added-fiber products rich in β-glucan and psyllium may allow them to reach their fiber goals without increasing caloric intake.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-04-29</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>5</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5051471</prism:doi>
	<prism:startingPage>1471</prism:startingPage>
		<prism:endingPage>1487</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Major Cereal Grain Fibers and Psyllium in Relation to Cardiovascular Health]]></dc:title>
    <dc:date>2013-04-29</dc:date>
	<dc:identifier>doi: 10.3390/nu5051471</dc:identifier>
    	<dc:creator>Adam Bernstein</dc:creator>
		<dc:creator>Brigid Titgemeier</dc:creator>
		<dc:creator>Kristin Kirkpatrick</dc:creator>
		<dc:creator>Mladen Golubic</dc:creator>
		<dc:creator>Michael Roizen</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/4/1456">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1456-1470: Zinc Supplementation Alters Plasma Aluminum and Selenium Status of Patients Undergoing Dialysis: A Pilot Study]]></title>
	<link>http://www.mdpi.com/2072-6643/5/4/1456</link>
	<description>End stage renal disease patients undergoing long-term dialysis are at risk for abnormal concentrations of certain essential and non-essential trace metals and high oxidative stress. We evaluated the effects of zinc (Zn) supplementation on plasma aluminum (Al) and selenium (Se) concentrations and oxidative stress in chronic dialysis patients. Zn-deficient patients receiving continuous ambulatory peritoneal dialysis or hemodialysis were divided into two groups according to plasma Al concentrations (HA group,  Al &amp;amp;gt; 50 μg/L; and MA group, Al &amp;amp;gt; 30 to ≤ 50 μg/L). All patients received daily oral Zn supplements for two months. Age- and gender-matched healthy individuals did not receive Zn supplement. Clinical variables were assessed before, at one month, and after the supplementation period. Compared with healthy subjects, patients had significantly lower baseline plasma Se concentrations and higher oxidative stress status. After two-month Zn treatment, these patients had higher plasma Zn and Se concentrations, reduced plasma Al concentrations and oxidative stress. Furthermore, increased plasma Zn concentrations were related to the concentrations of Al, Se, oxidative product malondialdehyde (MDA), and antioxidant enzyme superoxide dismutase activities. In conclusion, Zn supplementation ameliorates abnormally high plasma Al concentrations and oxidative stress and improves Se status in long-term dialysis patients.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-04-22</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5041456</prism:doi>
	<prism:startingPage>1456</prism:startingPage>
		<prism:endingPage>1470</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Zinc Supplementation Alters Plasma Aluminum and Selenium Status of Patients Undergoing Dialysis: A Pilot Study]]></dc:title>
    <dc:date>2013-04-22</dc:date>
	<dc:identifier>doi: 10.3390/nu5041456</dc:identifier>
    	<dc:creator>Chih-Hung Guo</dc:creator>
		<dc:creator>Pei-Chung Chen</dc:creator>
		<dc:creator>Guoo-Shyng Hsu</dc:creator>
		<dc:creator>Chia-Liang Wang</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/4/1436">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1436-1455: Short Term (14 Days) Consumption of Insoluble Wheat Bran Fibre-Containing Breakfast Cereals Improves Subjective Digestive Feelings, General Wellbeing and Bowel Function  in a Dose Dependent Manner]]></title>
	<link>http://www.mdpi.com/2072-6643/5/4/1436</link>
	<description>This study investigated whether increasing insoluble (predominantly wheat bran) fibre over 14 days improves subjective digestive feelings, general wellbeing and bowel function. A single centre, multi-site, open, within subjects design with a 14 day  non-intervention (baseline) monitoring period followed by a 14 day fibre consumption (intervention) period was performed. 153 low fibre consumers (&amp;amp;lt;15 g/day AOAC 985.29) completed a daily symptom diary for 14 days after which they consumed one bowl of  ready-to-eat breakfast cereal containing at least 5.4 g fibre (3.5 g from wheat bran) for  14 days and completed a daily symptom diary. Significant improvements were demonstrated in subjective perception of bowel function (e.g., ease of defecation) and digestive feelings (bloating, constipation, feeling sluggish and digestive discomfort). Significant improvements were also found in subjective perception of general wellbeing (feeling less fat, more mentally alert, slim, happy and energetic whilst experiencing less stress, mental and physical tiredness, difficulty concentrating and fewer headaches). In general, improvements in study outcomes increased with increasing cereal/fibre consumption. However, consuming an additional minimum 5.4 g of fibre (3.5 g wheat bran) per day was shown to deliver measurable and significant benefits for digestive health, comfort and wellbeing. Encouraging consumption of relatively small amounts of wheat bran could also provide an effective method of increasing overall fibre consumption.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-04-22</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5041436</prism:doi>
	<prism:startingPage>1436</prism:startingPage>
		<prism:endingPage>1455</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Short Term (14 Days) Consumption of Insoluble Wheat Bran Fibre-Containing Breakfast Cereals Improves Subjective Digestive Feelings, General Wellbeing and Bowel Function  in a Dose Dependent Manner]]></dc:title>
    <dc:date>2013-04-22</dc:date>
	<dc:identifier>doi: 10.3390/nu5041436</dc:identifier>
    	<dc:creator>Clare Lawton</dc:creator>
		<dc:creator>Jenny Walton</dc:creator>
		<dc:creator>Alexa Hoyland</dc:creator>
		<dc:creator>Elaine Howarth</dc:creator>
		<dc:creator>Peter Allan</dc:creator>
		<dc:creator>David Chesters</dc:creator>
		<dc:creator>Louise Dye</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/4/1417">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1417-1435: Fiber and Prebiotics: Mechanisms and Health Benefits]]></title>
	<link>http://www.mdpi.com/2072-6643/5/4/1417</link>
	<description>The health benefits of dietary fiber have long been appreciated. Higher intakes of dietary fiber are linked to less cardiovascular disease and fiber plays a role in gut health, with many effective laxatives actually isolated fiber sources. Higher intakes of fiber are linked to lower body weights. Only polysaccharides were included in dietary fiber originally, but more recent definitions have included oligosaccharides as dietary fiber, not based on their chemical measurement as dietary fiber by the accepted total dietary fiber (TDF) method, but on their physiological effects. Inulin, fructo-oligosaccharides, and other oligosaccharides are included as fiber in food labels in the US. Additionally, oligosaccharides are the best known “prebiotics”, “a selectively fermented ingredient that allows specific changes, both in the composition and/or activity in the gastrointestinal microflora that confers benefits upon host well-bring and health.” To date, all known and suspected prebiotics are carbohydrate compounds, primarily oligosaccharides, known to resist digestion in the human small intestine and reach the colon where they are fermented by the gut microflora. Studies have provided evidence that inulin and oligofructose (OF), lactulose, and resistant starch (RS) meet all aspects of the definition, including the stimulation of Bifidobacterium, a beneficial bacterial genus. Other isolated carbohydrates and carbohydrate-containing foods, including galactooligosaccharides (GOS), transgalactooligosaccharides (TOS), polydextrose, wheat dextrin, acacia gum, psyllium, banana, whole grain wheat, and whole grain corn also have prebiotic effects.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-04-22</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5041417</prism:doi>
	<prism:startingPage>1417</prism:startingPage>
		<prism:endingPage>1435</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Fiber and Prebiotics: Mechanisms and Health Benefits]]></dc:title>
    <dc:date>2013-04-22</dc:date>
	<dc:identifier>doi: 10.3390/nu5041417</dc:identifier>
    	<dc:creator>Joanne Slavin</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/4/1384">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1384-1416: Iodine and Mental Development of Children 5 Years Old and Under: A Systematic Review and Meta-Analysis]]></title>
	<link>http://www.mdpi.com/2072-6643/5/4/1384</link>
	<description>Several reviews and meta-analyses have examined the effects of iodine on mental development. None focused on young children, so they were incomplete in summarizing the effects on this important age group. The current systematic review therefore examined the relationship between iodine and mental development of children  5 years old and under. A systematic review of articles using Medline (1980–November 2011) was carried out. We organized studies according to four designs: (1) randomized controlled trial with iodine supplementation of mothers; (2) non-randomized trial with iodine supplementation of mothers and/or infants; (3) prospective cohort study stratified by pregnant women’s iodine status; (4) prospective cohort study stratified by newborn iodine status. Average effect sizes for these four designs were 0.68 (2 RCT studies),  0.46 (8 non-RCT studies), 0.52 (9 cohort stratified by mothers’ iodine status), and  0.54 (4 cohort stratified by infants’ iodine status). This translates into 6.9 to 10.2 IQ points lower in iodine deficient children compared with iodine replete children. Thus, regardless of study design, iodine deficiency had a substantial impact on mental development. Methodological concerns included weak study designs, the omission of important confounders, small sample sizes, the lack of cluster analyses, and the lack of separate analyses of verbal and non-verbal subtests. Quantifying more precisely the contribution of iodine deficiency to delayed mental development in young children requires more  well-designed randomized controlled trials, including ones on the role of iodized salt.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-04-22</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5041384</prism:doi>
	<prism:startingPage>1384</prism:startingPage>
		<prism:endingPage>1416</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Iodine and Mental Development of Children 5 Years Old and Under: A Systematic Review and Meta-Analysis]]></dc:title>
    <dc:date>2013-04-22</dc:date>
	<dc:identifier>doi: 10.3390/nu5041384</dc:identifier>
    	<dc:creator>Karim Bougma</dc:creator>
		<dc:creator>Frances Aboud</dc:creator>
		<dc:creator>Kimberly Harding</dc:creator>
		<dc:creator>Grace Marquis</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/4/1366">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1366-1383: At-Risk Serum Cholesterol Profile at Both Ends of the Nutrition Spectrum in West African Adults? The Benin Study]]></title>
	<link>http://www.mdpi.com/2072-6643/5/4/1366</link>
	<description>Low HDL-cholesterol (HDL-C), using as cut-offs 1.03 mmol/L in men and 1.29 mmol/L in women, was observed in more than 25% apparently healthy adults  (n = 541) in a cross-sectional study on nutrition transition and cardiometabolic risk factors (CMRF) in Benin, West Africa. Both overweight/obesity (35.3%) and underweight (11.3%) were present, displaying the double burden of malnutrition. We examined in more depth the association of low HDL-C with nutrition and with other CMRF. Metabolic syndrome components were assessed, plus the ratio of total cholesterol (TC)/HDL-C and serum homocysteine. Insulin resistance was based on Homeostasis Model Assessment. We also measured BMI and body composition by bio-impedance. Dietary quality was appraised with two non-consecutive 24 h recalls. Low HDL-C was associated with much higher TC/HDL-C and more abdominal obesity in men and women and with more insulin resistance in women. The rate of low HDL-C was highest (41.9%) among the overweight/obese subjects (BMI ≥ 25), but it also reached 31.1% among the underweight (BMI &amp;amp;lt; 18.5), compared with 17.3% among normal-weight subjects (p &amp;amp;lt; 0.001). Lower dietary micronutrient adequacy, in particular, in vitamins A, B3, B12, zinc and calcium, was associated with low HDL-C when controlling for several confounders. This suggests  that at-risk lipoprotein cholesterol may be associated with either underweight or overweight/obesity and with poor micronutrient intake.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-04-19</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5041366</prism:doi>
	<prism:startingPage>1366</prism:startingPage>
		<prism:endingPage>1383</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[At-Risk Serum Cholesterol Profile at Both Ends of the Nutrition Spectrum in West African Adults? The Benin Study]]></dc:title>
    <dc:date>2013-04-19</dc:date>
	<dc:identifier>doi: 10.3390/nu5041366</dc:identifier>
    	<dc:creator>Hélène Delisle</dc:creator>
		<dc:creator>Gervais Ntandou</dc:creator>
		<dc:creator>Roger Sodjinou</dc:creator>
		<dc:creator>Charles Couillard</dc:creator>
		<dc:creator>Jean-Pierre Després</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/4/1349">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1349-1365: Selenium Supranutrition: Are the Potential Benefits of Chemoprevention Outweighed by the Promotion of Diabetes and Insulin Resistance?]]></title>
	<link>http://www.mdpi.com/2072-6643/5/4/1349</link>
	<description>Selenium was considered a toxin until 1957, when this mineral was shown to be essential in the prevention of necrotic liver damage in rats. The hypothesis of selenium chemoprevention is principally formulated by the observations that cancer incidence is inversely associated with selenium status. However, recent clinical and epidemiological studies demonstrate a role for some selenoproteins in exacerbating or promoting other disease states, specifically type 2 diabetes, although other data support a role of selenium in stimulating insulin sensitivity. Therefore, it is clear that our understanding in the role of selenium in glucose metabolism and chemoprevention is inadequate and incomplete. Research exploring the role of selenium in individual healthcare is of upmost importance and possibly will help explain how selenium is a double-edged sword in the pathologies of chronic diseases.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-04-19</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5041349</prism:doi>
	<prism:startingPage>1349</prism:startingPage>
		<prism:endingPage>1365</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Selenium Supranutrition: Are the Potential Benefits of Chemoprevention Outweighed by the Promotion of Diabetes and Insulin Resistance?]]></dc:title>
    <dc:date>2013-04-19</dc:date>
	<dc:identifier>doi: 10.3390/nu5041349</dc:identifier>
    	<dc:creator>Caroline Rocourt</dc:creator>
		<dc:creator>Wen-Hsing Cheng</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/4/1336">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1336-1348: Comparison between Calcitriol and Calcitriol Plus Low-Dose Cinacalcet for the Treatment of Moderate to Severe Secondary Hyperparathyroidism in Chronic Dialysis Patients]]></title>
	<link>http://www.mdpi.com/2072-6643/5/4/1336</link>
	<description>Aim: Uremic hyperparathyroidism (UHPT) has been shown to contribute to the development and progression of chronic kidney disease—mineral bone disorder. UHPT is frequently observed in chronic dialysis patients, and patients with UHPT are associated with increased risk of all-cause and cardiovascular mortality. Cinacalcet is a novel agent that increases sensitivity to the calcium-sensing receptor and is approved for control of UHPT. Nevertheless, cinacalcet is costly and information regarding efficacy of low-dose cinacalcet on UHPT is limited. Methods: We conducted a retrospective study to evaluate treatment with either low-dose calcitriol combined with low-dose cinacalcet (25 mg)  (d-Cinacalcet) or calcitriol alone (VitD) in dialysis patients with moderate to severe UHPT. A total of 81 dialysis patients were enrolled (40 subjects in d-Cinacalcet group and  41 subjects in VitD group). Demographic data including age, gender, duration on dialysis and biochemical data were reviewed and recorded. Results: At the end of the study, the intact parathyroid hormone (iPTH) levels of the d-Cinacalcet group declined significantly (from 1166.0 ± 469.3 pg/mL to 679.8 ± 421.6 pg/mL, p &amp;amp;lt; 0.0001), while there was  no significant change in the VitD group. Significant decrease of serum calcium  (Ca: 9.9 ± 0.6 mg/dL vs. 9.6 ± 0.8 mg/dL, p = 0.002), phosphorus (P: 5.9 ± 1.3 mg/dL vs. 4.9 ± 0.9 mg/dL, p &amp;amp;lt; 0.0001) and calcium phosphate product (Ca × P: 58.7 ± 15.0 mg2/dL2 vs. 46.9 ± 8.9 mg2/dL2, p &amp;amp;lt; 0.0001) were observed in the d-Cinacalcet group. In addition, the subjects in the d-Cinacalcet group had a greater proportion to achieve Kidney Disease Outcomes Quality Initiative (KDOQI)-recommended biochemical targets than the subjects in the VitD group (Ca: 48% vs. 24%; P: 78% vs. 32%; Ca × P: 85% vs. 37%; iPTH: 15% vs. 0%). Conclusions: We conclude that combination therapy of low-dose cinacalcet and calcitriol is more effective than calcitriol alone as a treatment for moderate and severe UHPT in chronic dialysis patients. Furthermore, this therapy is associated with improvement in hyperphosphatemia and hypercalcemia.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-04-19</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5041336</prism:doi>
	<prism:startingPage>1336</prism:startingPage>
		<prism:endingPage>1348</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Comparison between Calcitriol and Calcitriol Plus Low-Dose Cinacalcet for the Treatment of Moderate to Severe Secondary Hyperparathyroidism in Chronic Dialysis Patients]]></dc:title>
    <dc:date>2013-04-19</dc:date>
	<dc:identifier>doi: 10.3390/nu5041336</dc:identifier>
    	<dc:creator>Yueh-Ting Lee</dc:creator>
		<dc:creator>Hwee-Yeong Ng</dc:creator>
		<dc:creator>Chien-Chun Kuo</dc:creator>
		<dc:creator>Te-Chuan Chen</dc:creator>
		<dc:creator>Chien-Shing Wu</dc:creator>
		<dc:creator>Terry Chiu</dc:creator>
		<dc:creator>Wen-Chin Lee</dc:creator>
		<dc:creator>Chien-Te Lee</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/4/1316">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1316-1335: Undernutrition in Patients with COPD and Its Treatment]]></title>
	<link>http://www.mdpi.com/2072-6643/5/4/1316</link>
	<description>Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory disorder of the lung and whole body caused mainly by tobacco smoking. Patients with advanced COPD are in a state of undernutrition, referred to as pulmonary cachexia; the exercise performance and quality of life (QOL) of these patients are deteriorated, the vital prognosis is unfavorable, and the medico-economic burden posed by poorly nourished COPD patients is high. The mainstays of COPD treatment are pharmacotherapy, mainly with bronchodilators, and non-pharmacotherapeutic approaches such as respiratory rehabilitation and nutrition counseling. Nutritional supplement therapy, consisting primarily of high calorie intake, has been demonstrated to be effective for maintaining and improving the muscle strength and exercise tolerance in poorly nourished COPD patients. The efficacy of intake of various nutrients, besides a high calorie intake, for amelioration of the disease state of COPD has also been reported. The roles of adipokines in the pathophysiology of COPD have begun to receive attention recently, and not only their regulatory effects on appetite and nutritional status, but also their influence on systemic inflammation have been increasingly clarified. We review the papers on COPD and nutrition and discuss the role of nutritional supplement therapy in the treatment of COPD.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-04-18</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5041316</prism:doi>
	<prism:startingPage>1316</prism:startingPage>
		<prism:endingPage>1335</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Undernutrition in Patients with COPD and Its Treatment]]></dc:title>
    <dc:date>2013-04-18</dc:date>
	<dc:identifier>doi: 10.3390/nu5041316</dc:identifier>
    	<dc:creator>Masayuki Itoh</dc:creator>
		<dc:creator>Takao Tsuji</dc:creator>
		<dc:creator>Kenji Nemoto</dc:creator>
		<dc:creator>Hiroyuki Nakamura</dc:creator>
		<dc:creator>Kazutetsu Aoshiba</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/4/1301">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1301-1315: Alternative Sources of Omega-3 Fats: Can We Find  a Sustainable Substitute for Fish?]]></title>
	<link>http://www.mdpi.com/2072-6643/5/4/1301</link>
	<description>Increasing demand for eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) containing fish oils is putting pressure on fish species and numbers. Fisheries provide fish for human consumption, supplement production and fish feeds and are currently supplying fish at a maximum historical rate, suggesting mass-scale fishing is no longer sustainable. However, the health properties of EPA and DHA long-chain (LC) omega-3 polyunsaturated fatty acids (PUFA) demonstrate the necessity for these oils in our diets. EPA and DHA from fish oils show favourable effects in inflammatory bowel disease, some cancers and cardiovascular complications. The high prevalence of these diseases worldwide indicates the requirement for alternative sources of LC-PUFA. Strategies have included plant-based fish diets, although this may compromise the health benefits associated with fish oils. Alternatively, stearidonic acid, the product of α-linolenic acid desaturation, may act as an EPA-enhancing fatty acid. Additionally, algae oils may be a promising omega-3 PUFA source for the future. Algae are beneficial for multiple industries, offering a source of biodiesel and livestock feeds. However, further research is required to develop efficient and sustainable LC-PUFA production from algae. This paper summarises the recent research for developing prospective substitutes for omega-3 PUFA and the current limitations that are faced.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-04-18</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5041301</prism:doi>
	<prism:startingPage>1301</prism:startingPage>
		<prism:endingPage>1315</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Alternative Sources of Omega-3 Fats: Can We Find  a Sustainable Substitute for Fish?]]></dc:title>
    <dc:date>2013-04-18</dc:date>
	<dc:identifier>doi: 10.3390/nu5041301</dc:identifier>
    	<dc:creator>Georgia Lenihan-Geels</dc:creator>
		<dc:creator>Karen Bishop</dc:creator>
		<dc:creator>Lynnette Ferguson</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/4/1287">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1287-1300: Functionality of Fatty Acid Chemoreception: A Potential Factor in the Development of Obesity?]]></title>
	<link>http://www.mdpi.com/2072-6643/5/4/1287</link>
	<description>Excess dietary fat consumption is recognized as a strong contributing factor in the development of overweight and obesity. Understanding why some individuals are better than others at regulating fat intake will become increasingly important and emerging associative evidence implicates attenuated fatty acid sensing in both the oral cavity and gastrointestinal (GI) tract in the development of obesity. Functional implications of impaired fatty acid chemoreception include diminished activation of the gustatory system, the cephalic response and satiety. This review will focus on knowledge from animal and human studies supporting the existence of oral fatty acid chemoreception including putative oral detection mechanisms, and how sensitivity to fatty acids is associated with fat consumption and fatty food preference.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-04-17</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5041287</prism:doi>
	<prism:startingPage>1287</prism:startingPage>
		<prism:endingPage>1300</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Functionality of Fatty Acid Chemoreception: A Potential Factor in the Development of Obesity?]]></dc:title>
    <dc:date>2013-04-17</dc:date>
	<dc:identifier>doi: 10.3390/nu5041287</dc:identifier>
    	<dc:creator>Lisa Newman</dc:creator>
		<dc:creator>Rivkeh Haryono</dc:creator>
		<dc:creator>Russell Keast</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/4/1276">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1276-1286: Effects of Three-Month Intake of Synbiotic on Inflammation and Body Composition in the Elderly: A Pilot Study]]></title>
	<link>http://www.mdpi.com/2072-6643/5/4/1276</link>
	<description>We hypothesize that improvements in the gut microbiota are capable of ameliorating gut permeability and, consequently, reducing systemic inflammation and the risk of frailty. This study aims to evaluate some effects of synbiotic supplementation on inflammatory markers and the body composition of the elderly at risk of frailty. In a  double-blind study that lasted three months, 17 elderly individuals fulfilling one frailty criteria (grip strength) were randomly distributed into two groups: SYN (n = 9), daily intake of synbiotic (6 g Frutooligossacarides, 108 to 109 CFU Lactobacillus paracasei,  108 to 109 CFU Lactobacillus rhamnosus, 108 to 109 CFU Lactobacillus acidophilus and 108 to 109 CFU Bifidobacterium lactis), or placebo (maltodextrin; PLA; n = 8). Subjects were analyzed for anthropometric measurements, bioelectric impedance with vectorial analysis (BIVA), IL-6 and TNF-α. A comparison between groups did not show any difference for the variables investigated. In turn, individual analysis of electrical impedance (BIVA) demonstrated that the majority of SYN individuals maintained or improved their tissue hydration, when compared to the PLA group after supplementation. In conclusion, three months of synbiotic supplementation did not promote any significant changes in inflammatory cytokines or body composition, but demonstrated a trend towards a preservation of hydration status in apparently healthy elderly individuals.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-04-17</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5041276</prism:doi>
	<prism:startingPage>1276</prism:startingPage>
		<prism:endingPage>1286</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Effects of Three-Month Intake of Synbiotic on Inflammation and Body Composition in the Elderly: A Pilot Study]]></dc:title>
    <dc:date>2013-04-17</dc:date>
	<dc:identifier>doi: 10.3390/nu5041276</dc:identifier>
    	<dc:creator>João Neto</dc:creator>
		<dc:creator>Camila de Melo</dc:creator>
		<dc:creator>Sandra Ribeiro</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/4/1253">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1253-1275: Higher Serum 25-Hydroxyvitamin D Concentrations Associate with a Faster Recovery of Skeletal Muscle Strength after Muscular Injury]]></title>
	<link>http://www.mdpi.com/2072-6643/5/4/1253</link>
	<description>The primary purpose of this study was to identify if serum 25-hydroxyvitamin D (25(OH)D) concentrations predict muscular weakness after intense exercise. We hypothesized that pre-exercise serum 25(OH)D concentrations inversely predict  exercise-induced muscular weakness. Fourteen recreationally active adults participated in this study. Each subject had one leg randomly assigned as a control. The other leg performed an intense exercise protocol. Single-leg peak isometric force and blood 25(OH)D, aspartate and alanine aminotransferases, albumin, interferon (IFN)-γ, and interleukin-4 were measured prior to and following intense exercise. Following exercise, serum 25(OH)D concentrations increased (p &amp;amp;lt; 0.05) immediately, but within minutes, subsequently decreased (p &amp;amp;lt; 0.05). Circulating albumin increases predicted (p &amp;amp;lt; 0.005) serum 25(OH)D increases, while IFN-γ increases predicted (p &amp;amp;lt; 0.001) serum 25(OH)D decreases. Muscular weakness persisted within the exercise leg (p &amp;amp;lt; 0.05) and compared to the control leg (p &amp;amp;lt; 0.05) after the exercise protocol. Serum 25(OH)D concentrations inversely predicted (p &amp;amp;lt; 0.05) muscular weakness (i.e., control leg vs. exercise leg peak isometric force) immediately and days (i.e., 48-h and 72-h) after exercise, suggesting the attenuation of exercise-induced muscular weakness with increasing serum 25(OH)D prior to exercise. Based on these data, we conclude that pre-exercise serum 25(OH)D concentrations could influence the recovery of skeletal muscle strength after an acute bout of intense exercise.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-04-17</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5041253</prism:doi>
	<prism:startingPage>1253</prism:startingPage>
		<prism:endingPage>1275</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Higher Serum 25-Hydroxyvitamin D Concentrations Associate with a Faster Recovery of Skeletal Muscle Strength after Muscular Injury]]></dc:title>
    <dc:date>2013-04-17</dc:date>
	<dc:identifier>doi: 10.3390/nu5041253</dc:identifier>
    	<dc:creator>Tyler Barker</dc:creator>
		<dc:creator>Vanessa Henriksen</dc:creator>
		<dc:creator>Thomas Martins</dc:creator>
		<dc:creator>Harry Hill</dc:creator>
		<dc:creator>Carl Kjeldsberg</dc:creator>
		<dc:creator>Erik Schneider</dc:creator>
		<dc:creator>Brian Dixon</dc:creator>
		<dc:creator>Lindell Weaver</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/4/1241">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1241-1252: Antioxidant Effectiveness of Vegetable Powders on the Lipid and Protein Oxidative Stability of Cooked Turkey Meat Patties: Implications for Health]]></title>
	<link>http://www.mdpi.com/2072-6643/5/4/1241</link>
	<description>Lipid and protein oxidation decreases the shelf-life of foods and may result in formation of end-products potentially detrimental for health. Consumer pressure to decrease the use of synthetic phenolic antioxidants has encouraged identification of alternative compounds or extracts from natural sources. We have assessed whether inclusion of dried vegetable powders improves the oxidative stability of turkey meat patties. Such powders are not only potentially-rich sources of phenolic antioxidants, but also may impart additional health benefits, as inadequate vegetable consumption is a risk factor for heart disease and several cancers. In an accelerated oxidation system, six of eleven vegetable powders significantly (p &amp;amp;lt; 0.05) improved oxidative stability of patties by 20%–30% (spinach &amp;amp;lt; yellow pea &amp;amp;lt; onion &amp;amp;lt; red pepper &amp;amp;lt; green pea &amp;amp;lt; tomato). Improved lipid oxidative stability was strongly correlated with the decreased formation of protein carbonyls (r = 0.747, p &amp;amp;lt; 0.01). However, improved lipid stability could not be ascribed to phenolic acids nor recognized antioxidants, such as α- and γ-tocopherol, despite their significant (p &amp;amp;lt; 0.01) contribution to the total antioxidant capacity of the patties. Use of chemically complex vegetable powders offers an alternative to individual antioxidants for increasing shelf-life of animal-based food products and may also provide additional health benefits associated with increased vegetable intake.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-04-17</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5041241</prism:doi>
	<prism:startingPage>1241</prism:startingPage>
		<prism:endingPage>1252</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Antioxidant Effectiveness of Vegetable Powders on the Lipid and Protein Oxidative Stability of Cooked Turkey Meat Patties: Implications for Health]]></dc:title>
    <dc:date>2013-04-17</dc:date>
	<dc:identifier>doi: 10.3390/nu5041241</dc:identifier>
    	<dc:creator>Garry Duthie</dc:creator>
		<dc:creator>Fiona Campbell</dc:creator>
		<dc:creator>Charles Bestwick</dc:creator>
		<dc:creator>Sylvia Stephen</dc:creator>
		<dc:creator>Wendy Russell</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/4/1218">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1218-1240: Dyslipidemia in Obesity: Mechanisms and Potential Targets]]></title>
	<link>http://www.mdpi.com/2072-6643/5/4/1218</link>
	<description>Obesity has become a major worldwide health problem. In every single country in the world, the incidence of obesity is rising continuously and therefore, the associated morbidity, mortality and both medical and economical costs are expected to increase as well. The majority of these complications are related to co-morbid conditions that include coronary artery disease, hypertension, type 2 diabetes mellitus, respiratory disorders and dyslipidemia. Obesity increases cardiovascular risk through risk factors such as increased fasting plasma triglycerides, high LDL cholesterol, low HDL cholesterol, elevated blood glucose and insulin levels and high blood pressure. Novel lipid dependent, metabolic risk factors associated to obesity are the presence of the small dense LDL phenotype, postprandial hyperlipidemia with accumulation of atherogenic remnants and hepatic overproduction of apoB containing lipoproteins. All these lipid abnormalities are typical features of the metabolic syndrome and may be associated to a pro-inflammatory gradient which in part may originate in the adipose tissue itself and directly affect the endothelium. An important link between obesity, the metabolic syndrome and dyslipidemia, seems to be the development of insulin resistance in peripheral tissues leading to an enhanced hepatic flux of fatty acids from dietary sources, intravascular lipolysis and from adipose tissue resistant to the antilipolytic effects of insulin. The current review will focus on these aspects of lipid metabolism in obesity and potential interventions to treat the obesity related dyslipidemia.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-04-12</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5041218</prism:doi>
	<prism:startingPage>1218</prism:startingPage>
		<prism:endingPage>1240</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Dyslipidemia in Obesity: Mechanisms and Potential Targets]]></dc:title>
    <dc:date>2013-04-12</dc:date>
	<dc:identifier>doi: 10.3390/nu5041218</dc:identifier>
    	<dc:creator>Boudewijn Klop</dc:creator>
		<dc:creator>Jan Elte</dc:creator>
		<dc:creator>Manuel Cabezas</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/4/1200">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1200-1217: Vitamin C in Cultured Human (HeLa) Cells: Lack of Effect on DNA Protection and Repair]]></title>
	<link>http://www.mdpi.com/2072-6643/5/4/1200</link>
	<description>Aims: Dietary antioxidants, including vitamin C, may be in part responsible for the cancer-preventive effects of fruits and vegetables. Human intervention trials with clinical endpoints have failed to confirm their protective effects, and mechanistic studies have given inconsistent results. Our aim was to investigate antioxidant/ pro-oxidant effects of vitamin C at the cellular level. Experimental approach: We have used the comet assay to investigate effects of vitamin C on DNA damage, antioxidant status, and DNA repair, in HeLa (human tumor) cells, and HPLC to measure uptake of vitamin C into cells. Results: Even at concentrations in the medium as high as 200 μM, vitamin C did not increase the background level of strand breaks or of oxidized purines in nuclear DNA. Vitamin C is taken up by HeLa cells and accumulates to mM levels. Preincubation of cells with vitamin C did not render them resistant to strand breakage induced by H2O2 or to purine oxidation by photosensitizer plus light. Vitamin C had no effect on the rate of repair of strand breaks or oxidized bases by HeLa cells. However, vitamin C at a concentration of less than 1 μM, or extract from cells preincubated for 6 h with vitamin C, was able to induce damage (strand breaks) in lysed, histone-depleted nuclei (nucleoids). Conclusion: In these cultured human cells, vitamin C displays neither antioxidant nor pro-oxidant properties; nor does it affect DNA strand break or base excision repair.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-04-09</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5041200</prism:doi>
	<prism:startingPage>1200</prism:startingPage>
		<prism:endingPage>1217</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Vitamin C in Cultured Human (HeLa) Cells: Lack of Effect on DNA Protection and Repair]]></dc:title>
    <dc:date>2013-04-09</dc:date>
	<dc:identifier>doi: 10.3390/nu5041200</dc:identifier>
    	<dc:creator>Amaya Azqueta</dc:creator>
		<dc:creator>Solange Costa</dc:creator>
		<dc:creator>Yolanda Lorenzo</dc:creator>
		<dc:creator>Nasser Bastani</dc:creator>
		<dc:creator>Andrew Collins</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/4/1186">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1186-1199: Perioperative Immunonutrition in Well-Nourished Patients Undergoing Surgery for Head and Neck Cancer: Evaluation of Inflammatory and Immunologic Outcomes]]></title>
	<link>http://www.mdpi.com/2072-6643/5/4/1186</link>
	<description>Limited work is available on the benefits of nutritional support enriched with arginine and n-3 fatty acids in surgical patients with head and neck cancer, particularly if well-nourished. We conducted a pilot study in these patients to examine effects on inflammatory markers and clinical outcome. Patients scheduled for radical resection of the oral cavity were randomised to 5 day preoperative and 5 day postoperative Impact® (IMN, n = 4), or no preoperative supplementary nutrition and Isosource® postoperatively (STD, n = 4). Plasma fatty acids, C-reactive protein (CRP), tumour necrosis factor (TNF)-α, interleukin (IL)-6 and IL-10 were measured at baseline, day of surgery and on postoperative days (POD) 2, 4 and 10. Postoperative complications were recorded. The (eicosapentaenoic acid plus docosahexaenoic acid) to arachidonic acid ratio was significantly higher in IMN patients on POD 2, 4 and 10 (P &amp;amp;lt; 0.01). While not statistically significant, CRP, TNF-α, and IL-6 concentrations were higher in the STD group on POD2 while IL-10 was lower. Median length of stay was 10 (range 10–43) days in the IMN group and 21.5 (7–24) days in the STD group. Five complications were seen in the STD group and two in the IMN group. The results support the need for a larger trial focusing on clinical outcome.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-04-09</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5041186</prism:doi>
	<prism:startingPage>1186</prism:startingPage>
		<prism:endingPage>1199</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Perioperative Immunonutrition in Well-Nourished Patients Undergoing Surgery for Head and Neck Cancer: Evaluation of Inflammatory and Immunologic Outcomes]]></dc:title>
    <dc:date>2013-04-09</dc:date>
	<dc:identifier>doi: 10.3390/nu5041186</dc:identifier>
    	<dc:creator>Amy Turnock</dc:creator>
		<dc:creator>Philip Calder</dc:creator>
		<dc:creator>Annette West</dc:creator>
		<dc:creator>Mark Izzard</dc:creator>
		<dc:creator>Randall Morton</dc:creator>
		<dc:creator>Lindsay Plank</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/4/1169">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1169-1185: Dietary Sources of Lutein and Zeaxanthin Carotenoids and Their Role in Eye Health]]></title>
	<link>http://www.mdpi.com/2072-6643/5/4/1169</link>
	<description>The eye is a major sensory organ that requires special care for a healthy and productive lifestyle. Numerous studies have identified lutein and zeaxanthin to be essential components for eye health. Lutein and zeaxanthin are carotenoid pigments that impart yellow or orange color to various common foods such as cantaloupe, pasta, corn, carrots, orange/yellow peppers, fish, salmon and eggs. Their role in human health, in particular the health of the eye, is well established from epidemiological, clinical and interventional studies. They constitute the main pigments found in the yellow spot of the human retina which protect the macula from damage by blue light, improve visual acuity and scavenge harmful reactive oxygen species. They have also been linked with reduced risk of  age-related macular degeneration (AMD) and cataracts. Research over the past decade has focused on the development of carotenoid-rich foods to boost their intake especially in the elderly population. The aim of this article is to review recent scientific evidences supporting the benefits of lutein and zexanthin in preventing the onset of two major  age-related eye diseases with diets rich in these carotenoids. The review also lists major dietary sources of lutein and zeaxanthin and refers to newly developed foods, daily intake, bioavailability and physiological effects in relation to eye health. Examples of the newly developed high-lutein functional foods are also underlined.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-04-09</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5041169</prism:doi>
	<prism:startingPage>1169</prism:startingPage>
		<prism:endingPage>1185</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Dietary Sources of Lutein and Zeaxanthin Carotenoids and Their Role in Eye Health]]></dc:title>
    <dc:date>2013-04-09</dc:date>
	<dc:identifier>doi: 10.3390/nu5041169</dc:identifier>
    	<dc:creator>El-Sayed Abdel-Aal</dc:creator>
		<dc:creator>Humayoun Akhtar</dc:creator>
		<dc:creator>Khalid Zaheer</dc:creator>
		<dc:creator>Rashida Ali</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/4/1149">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1149-1168: Is Selenium a Potential Treatment for Cancer Metastasis?]]></title>
	<link>http://www.mdpi.com/2072-6643/5/4/1149</link>
	<description>Selenium (Se) is an essential micronutrient that functions as a redox gatekeeper through its incorporation into proteins to alleviate oxidative stress in cells. Although the epidemiological data are somewhat controversial, the results of many studies suggest that inorganic and organic forms of Se negatively affect cancer progression, and that several selenoproteins, such as GPXs, also play important roles in tumor development. Recently, a few scientists have examined the relationship between Se and metastasis, a late event in cancer progression, and have evaluated the potential of Se as an anti-angiogenesis or  anti-metastasis agent. In this review, we present the current knowledge about Se compounds and selenoproteins, and their effects on the development of metastasis, with an emphasis on cell migration, invasion, and angiogenesis. In the cancers of breast, prostate, colorectal, fibrosarcoma, melanoma, liver, lung, oral squamous cell carcinoma, and brain glioma, there is either clinical evidence linking selenoproteins, such as thioredoxin reductase-1 to lymph node metastasis; in vitro studies indicating that Se compounds and selenoproteins inhibited cell motility, migration, and invasion, and reduced angiogenic factors in some of these cancer cells; or animal studies showing that Se supplementation resulted in reduced microvessel density and metastasis. Together, these data support the notion that Se may be an anti-metastastatic element in addition to being a cancer preventative agent.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-04-08</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5041149</prism:doi>
	<prism:startingPage>1149</prism:startingPage>
		<prism:endingPage>1168</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Is Selenium a Potential Treatment for Cancer Metastasis?]]></dc:title>
    <dc:date>2013-04-08</dc:date>
	<dc:identifier>doi: 10.3390/nu5041149</dc:identifier>
    	<dc:creator>Yu-Chi Chen</dc:creator>
		<dc:creator>K. Prabhu</dc:creator>
		<dc:creator>Andrea Mastro</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/4/1122">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1122-1148: Selenium and Prostate Cancer Prevention: Insights from the Selenium and Vitamin E Cancer Prevention Trial (SELECT)]]></title>
	<link>http://www.mdpi.com/2072-6643/5/4/1122</link>
	<description>The Selenium and Vitamin E Cancer Prevention Trial (SELECT) was conducted to assess the efficacy of selenium and vitamin E alone, and in combination, on the incidence of prostate cancer. This randomized, double-blind, placebo-controlled, 2 × 2 factorial design clinical trial found that neither selenium nor vitamin E reduced the incidence of prostate cancer after seven years and that vitamin E was associated with a 17% increased risk of prostate cancer compared to placebo. The null result was surprising given the strong preclinical and clinical evidence suggesting chemopreventive activity of selenium. Potential explanations for the null findings include the agent formulation and dose, the characteristics of the cohort, and the study design. It is likely that only specific subpopulations may benefit from selenium supplementation; therefore, future studies should consider the baseline selenium status of the participants, age of the cohort, and genotype of specific selenoproteins, among other characteristics, in order to determine the activity of selenium in cancer prevention.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-04-03</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5041122</prism:doi>
	<prism:startingPage>1122</prism:startingPage>
		<prism:endingPage>1148</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Selenium and Prostate Cancer Prevention: Insights from the Selenium and Vitamin E Cancer Prevention Trial (SELECT)]]></dc:title>
    <dc:date>2013-04-03</dc:date>
	<dc:identifier>doi: 10.3390/nu5041122</dc:identifier>
    	<dc:creator>Holly Nicastro</dc:creator>
		<dc:creator>Barbara Dunn</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/4/1110">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1110-1121: Use of Dietary Supplements in Patients Seeking Treatment at a Periodontal Clinic]]></title>
	<link>http://www.mdpi.com/2072-6643/5/4/1110</link>
	<description>Dietary supplement use may modify the risk of periodontal disease but effects on wound healing after periodontal procedures are less clear. This study characterized dietary supplement use by male and female patients (n = 376) attending a periodontal  clinic—information that is essential for evidence-based intervention studies that may improve patient outcomes after periodontal procedures. Calcium, vitamin D, multivitamin and vitamin C were most commonly used. A greater (p ≤ 0.05) number of males took no supplements compared to females, and more (p ≤ 0.05) females than males took ≥ four supplements. Females took more (p ≤ 0.05) calcium, vitamin D, fish oil, green tea, magnesium, omega 3,6,9 and B vitamin complex. Younger patients (31–50 years) had the highest (p ≤ 0.05) frequency of no supplement use compared to older age groups. Patients over age 50 had a higher (p ≤ 0.05) frequency of using ≥ four supplements including calcium and vitamin D. Supplement use was lower (p ≤ 0.05) in smokers, particularly for calcium, fish oil, green tea and vitamin D. In conclusion, females, older individuals and non-smokers have higher supplement use. Future dietary intervention studies can focus on supplements with known biological activities—anti-inflammatory, antioxidant or osteogenic activity—that may enhance wound healing after reconstructive periodontal procedures.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-04-02</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5041110</prism:doi>
	<prism:startingPage>1110</prism:startingPage>
		<prism:endingPage>1121</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Use of Dietary Supplements in Patients Seeking Treatment at a Periodontal Clinic]]></dc:title>
    <dc:date>2013-04-02</dc:date>
	<dc:identifier>doi: 10.3390/nu5041110</dc:identifier>
    	<dc:creator>Bryan Johnston</dc:creator>
		<dc:creator>Peter Fritz</dc:creator>
		<dc:creator>Wendy Ward</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/4/1098">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1098-1109: Expanding Awareness of Docosahexaenoic Acid  during Pregnancy]]></title>
	<link>http://www.mdpi.com/2072-6643/5/4/1098</link>
	<description>Pregnant women do not currently meet the consensus recommendation for docosahexaenoic acid (DHA) (≥200 mg/day). Pregnant women in Australia are not receiving information on the importance of DHA during pregnancy. DHA pregnancy education materials were developed using current scientific literature, and tested for readability and design aesthetics. The study aimed to evaluate their usefulness, the desire for pregnant women to receive these materials and whether a larger separate study (using a control group) is warranted to evaluate the influence the materials may have on increasing DHA consumption in pregnant women in Australia. Pregnant women (N = 118) were recruited at antenatal clinics at two NSW hospitals. Participants completed a 16-item questionnaire and DHA educational materials (pamphlet and shopping card) were provided. Participants were contacted via phone two weeks later and completed the second questionnaire (25-item, N = 74). Statistics were conducted in SPSS and qualitative data were analysed to identify common themes. Ninety three percent of women found the materials useful, with the main reason being it expanded their knowledge of DHA food sources. Only 34% of women had received prior information on DHA, yet 68% said they would like to receive information. Due to the small sample size and lack of a control group, this small study cannot provide a cause and effect relationship between the materials and nutrition related behaviours or knowledge, however the results indicate a potential positive influence towards increased fish consumption and awareness of DHA containing foods. This suggests a larger study, with a control group is warranted to identify the impact such materials could have on Australian pregnant women.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-04-02</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5041098</prism:doi>
	<prism:startingPage>1098</prism:startingPage>
		<prism:endingPage>1109</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Expanding Awareness of Docosahexaenoic Acid  during Pregnancy]]></dc:title>
    <dc:date>2013-04-02</dc:date>
	<dc:identifier>doi: 10.3390/nu5041098</dc:identifier>
    	<dc:creator>Rebecca Emmett</dc:creator>
		<dc:creator>Shann Akkersdyk</dc:creator>
		<dc:creator>Heather Yeatman</dc:creator>
		<dc:creator>Barbara Meyer</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/4/1081">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1081-1097: Issues of Fish Consumption for Cardiovascular Disease  Risk Reduction]]></title>
	<link>http://www.mdpi.com/2072-6643/5/4/1081</link>
	<description>Increasing fish consumption is recommended for intake of omega-3 (n-3) fatty acids and to confer benefits for the risk reduction of cardiovascular disease (CVD). Most Americans are not achieving intake levels that comply with current recommendations. It is the goal of this review to provide an overview of the issues affecting this shortfall of intake. Herein we describe the relationship between fish intake and CVD risk reduction as well as the other nutritional contributions of fish to the diet. Currently recommended intake levels are described and estimates of fish consumption at a food disappearance and individual level are reported. Risk and benefit factors influencing the choice to consume fish are outlined. The multiple factors influencing fish availability from global capture and aquaculture are described as are other pertinent issues of fish nutrition, production, sustainability, and consumption patterns. This review highlights some of the work that needs to be carried out to meet the demand for fish and to positively affect intake levels to meet fish intake recommendations for CVD risk reduction.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-03-28</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5041081</prism:doi>
	<prism:startingPage>1081</prism:startingPage>
		<prism:endingPage>1097</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Issues of Fish Consumption for Cardiovascular Disease  Risk Reduction]]></dc:title>
    <dc:date>2013-03-28</dc:date>
	<dc:identifier>doi: 10.3390/nu5041081</dc:identifier>
    	<dc:creator>Susan Raatz</dc:creator>
		<dc:creator>Jeffrey Silverstein</dc:creator>
		<dc:creator>Lisa Jahns</dc:creator>
		<dc:creator>Matthew Picklo</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/4/1071">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1071-1080: Effect of Diets Differing in Glycemic Index and Glycemic Load on Cardiovascular Risk Factors: Review of Randomized Controlled-Feeding Trials]]></title>
	<link>http://www.mdpi.com/2072-6643/5/4/1071</link>
	<description>Despite a considerable amount of data available on the relationship between dietary glycemic index (GI) or load (GL) and cardiovascular disease (CVD) risk factors, in aggregate, the area remains unsettled. The aim of the present review was to summarize the effect of diets differing in GI/GL on CVD risk factors, by examining randomized controlled-feeding trials that provided all food and beverages to adult participants. The studies included a low and high GI/GL diet phase for a minimum of four weeks duration, and reported at least one outcome related to CVD risk; glucose homeostasis, lipid profile or inflammatory status. Ten publications representing five trials were identified. The low GI/GL compared to the high GI/GL diet unexpectedly resulted in significantly higher fasting glucose concentrations in two of the trials, and a lower area under the curve for glucose and insulin in one of the two studies during an oral glucose tolerance test. Response of plasma total, low density lipoprotein and high density lipoprotein cholesterol concentrations was conflicting in two of the studies for which data were available. There was either weak or no effect on inflammatory markers. The results of the five randomized controlled trials satisfying the inclusion criteria suggest inconsistent effects of the GI/GL value of the diet on CVD risk factors.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-03-28</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5041071</prism:doi>
	<prism:startingPage>1071</prism:startingPage>
		<prism:endingPage>1080</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Effect of Diets Differing in Glycemic Index and Glycemic Load on Cardiovascular Risk Factors: Review of Randomized Controlled-Feeding Trials]]></dc:title>
    <dc:date>2013-03-28</dc:date>
	<dc:identifier>doi: 10.3390/nu5041071</dc:identifier>
    	<dc:creator>Aleksandra Kristo</dc:creator>
		<dc:creator>Nirupa Matthan</dc:creator>
		<dc:creator>Alice Lichtenstein</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/4/1058">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1058-1070: Standardised Parenteral Nutrition]]></title>
	<link>http://www.mdpi.com/2072-6643/5/4/1058</link>
	<description>Parenteral nutrition (PN) has become an integral part of clinical management of very low birth weight premature neonates. Traditionally different components of PN are prescribed individually considering requirements of an individual neonate (IPN). More recently, standardised PN formulations (SPN) for preterm neonates have been assessed and may have advantages including better provision of nutrients, less prescription and administration errors, decreased risk of infection, and cost savings. The recent introduction of triple-chamber bag that provides total nutrient admixture for neonates may have additional advantage of decreased risk of contamination and ease of administration.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-03-28</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5041058</prism:doi>
	<prism:startingPage>1058</prism:startingPage>
		<prism:endingPage>1070</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Standardised Parenteral Nutrition]]></dc:title>
    <dc:date>2013-03-28</dc:date>
	<dc:identifier>doi: 10.3390/nu5041058</dc:identifier>
    	<dc:creator>Karen Simmer</dc:creator>
		<dc:creator>Abhijeet Rakshasbhuvankar</dc:creator>
		<dc:creator>Girish Deshpande</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/4/1024">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1024-1057: Selenium Toxicity from a Misformulated Dietary Supplement, Adverse Health Effects, and the Temporal Response in the Nail Biologic Monitor]]></title>
	<link>http://www.mdpi.com/2072-6643/5/4/1024</link>
	<description>Use of dietary supplements in the U.S. has increased steadily over the last  25 years. While misformulation is uncommon, the consequences can be serious. A March 2008 voluntary market recall removed supplement products responsible for the most serious selenium toxicity outbreak that has occurred in the U.S. We quantified selenium concentrations in the misformulated supplement products, measured the temporal response in the nail biologic monitor, and associated exposure to self-reported selenosis symptoms. Subjects recruited through state health departments and referrals provided samples of the misformulated supplement products, exposure information, monthly toenail and or fingernail clippings or onycholysitic nail fragments, and listed their newly onset adverse health effects attributed to selenium toxicity. Ninety-seven subjects enrolled and submitted at least one test sample. Peak selenium concentrations (up to 18.3 and 44.1 μg/g for toenails and fingernails, respectively) were measured. Multiple samples (52 total) of all six recalled supplement lots were analyzed ranging from 22,300 to 32,200 μg selenium per daily dose. Average consumption was 30.9 ± 13.9 doses; 73 subjects provided follow-up data on selenosis symptoms at 2.50 ± 0.14 years. Nail samples accurately reflect exposure in this selenium toxicity outbreak, which resulted in long-term/permanent adverse health effects.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-03-28</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>4</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5041024</prism:doi>
	<prism:startingPage>1024</prism:startingPage>
		<prism:endingPage>1057</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Selenium Toxicity from a Misformulated Dietary Supplement, Adverse Health Effects, and the Temporal Response in the Nail Biologic Monitor]]></dc:title>
    <dc:date>2013-03-28</dc:date>
	<dc:identifier>doi: 10.3390/nu5041024</dc:identifier>
    	<dc:creator>John Morris</dc:creator>
		<dc:creator>Stacy Crane</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/3/1002">
	<title><![CDATA[Nutrients, Vol. 5, Pages 1002-1023: Mineral Metabolic Abnormalities and Mortality in  Dialysis Patients]]></title>
	<link>http://www.mdpi.com/2072-6643/5/3/1002</link>
	<description>The survival rate of dialysis patients, as determined by risk factors such as hypertension, nutritional status, and chronic inflammation, is lower than that of the general population. In addition, disorders of bone mineral metabolism are independently related to mortality and morbidity associated with cardiovascular disease and fracture in dialysis patients. Hyperphosphatemia is an important risk factor of, not only secondary hyperparathyroidism, but also cardiovascular disease. On the other hand, the risk of death reportedly increases with an increase in adjusted serum calcium level, while calcium levels below the recommended target are not associated with a worsened outcome. Thus, the significance of target levels of serum calcium in dialysis patients is debatable. The consensus on determining optimal parathyroid function in dialysis patients, however, is yet to be established. Therefore, the contribution of phosphorus and calcium levels to prognosis is perhaps more significant. Elevated fibroblast growth factor 23 levels have also been shown to be associated with cardiovascular events and death. In this review, we examine the associations between mineral metabolic abnormalities including serum phosphorus, calcium, and parathyroid hormone and mortality in dialysis patients.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-03-22</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5031002</prism:doi>
	<prism:startingPage>1002</prism:startingPage>
		<prism:endingPage>1023</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Mineral Metabolic Abnormalities and Mortality in  Dialysis Patients]]></dc:title>
    <dc:date>2013-03-22</dc:date>
	<dc:identifier>doi: 10.3390/nu5031002</dc:identifier>
    	<dc:creator>Masanori Abe</dc:creator>
		<dc:creator>Kazuyoshi Okada</dc:creator>
		<dc:creator>Masayoshi Soma</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/3/981">
	<title><![CDATA[Nutrients, Vol. 5, Pages 981-1001: Hypertriglyceridemia]]></title>
	<link>http://www.mdpi.com/2072-6643/5/3/981</link>
	<description>Hypertriglyceridemia (HTG) is commonly encountered in lipid and cardiology clinics. Severe HTG warrants treatment because of the associated increased risk of acute pancreatitis. However, the need to treat, and the correct treatment approach for patients with mild to moderate HTG are issues for ongoing evaluation. In the past, it was felt that triglyceride does not directly contribute to development of atherosclerotic plaques. However, this view is evolving, especially for triglyceride-related fractions and variables measured in the non-fasting state. Our understanding of the etiology, genetics and classification of HTG states is also evolving. Previously, HTG was considered to be a dominant disorder associated with variation within a single gene. The old nomenclature includes the term “familial” in the names of several hyperlipoproteinemia (HLP) phenotypes that included HTG as part of their profile, including combined hyperlipidemia (HLP type 2B), dysbetalipoproteinemia (HLP type 3), simple HTG (HLP type 4) and mixed hyperlipidemia (HLP type 5). This old thinking has given way to the idea that genetic susceptibility to HTG results from cumulative effects of multiple genetic variants acting in concert. HTG most is often a “polygenic” or “multigenic” trait. However, a few rare autosomal recessive forms of severe HTG have been defined. Treatment depends on the overall clinical context, including severity of HTG, concomitant presence of other lipid disturbances, and the patient&#039;s global risk of cardiovascular disease. Therapeutic strategies include dietary counselling, lifestyle management, control of secondary factors, use of omega-3 preparations and selective use of pharmaceutical agents.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-03-22</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5030981</prism:doi>
	<prism:startingPage>981</prism:startingPage>
		<prism:endingPage>1001</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Hypertriglyceridemia]]></dc:title>
    <dc:date>2013-03-22</dc:date>
	<dc:identifier>doi: 10.3390/nu5030981</dc:identifier>
    	<dc:creator>Amanda Brahm</dc:creator>
		<dc:creator>Robert Hegele</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/3/971">
	<title><![CDATA[Nutrients, Vol. 5, Pages 971-980: Total Vitamin D Assay Comparison of the Roche Diagnostics “Vitamin D Total” Electrochemiluminescence Protein Binding Assay with the Chromsystems HPLC Method in a Population with both D2 and D3 forms of Vitamin D]]></title>
	<link>http://www.mdpi.com/2072-6643/5/3/971</link>
	<description>This study compared two methods of assaying the 25-hydroxylated metabolites of cholecalciferol (vitamin D3) and ergocalciferol (vitamin D2). A fully automated electrochemiluminescence assay from Roche Diagnostics and an HPLC based method from Chromsystems were used to measure vitamin D levels in surplus sera from 96 individuals, where the majority has the D2 form of the vitamin. Deming regression, concordance rate, correlation and Altman Bland agreement were performed. Seventy two subjects (75%) had a D2 concentration &amp;amp;gt;10 nmol/L while the remaining twenty four subjects had vitamin D2 concentration of less than 10 nmol/L by HPLC. Overall, the Roche Diagnostics method showed a negative bias of −2.59 ± 4.11 nmol/L on the e602 as compared to the HPLC with a concordance rate of 84%. The concordance rate was 91% in samples with D2 of less than 10 nmol/L and 82% in those with D2 concentration &amp;amp;gt;10 nmol/L. The overall correlation had an r value of 0.77. The r value was higher in samples with D2 levels of less than  10 nmol/L, r = 0.96, as compared to those with D2 values of greater than 10 nmol/L,  r = 0.74. The observed bias had little impact on clinical decision and therefore is  clinically acceptable.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-03-22</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5030971</prism:doi>
	<prism:startingPage>971</prism:startingPage>
		<prism:endingPage>980</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Total Vitamin D Assay Comparison of the Roche Diagnostics “Vitamin D Total” Electrochemiluminescence Protein Binding Assay with the Chromsystems HPLC Method in a Population with both D2 and D3 forms of Vitamin D]]></dc:title>
    <dc:date>2013-03-22</dc:date>
	<dc:identifier>doi: 10.3390/nu5030971</dc:identifier>
    	<dc:creator>Laila Abdel-Wareth</dc:creator>
		<dc:creator>Afrozul Haq</dc:creator>
		<dc:creator>Andrew Turner</dc:creator>
		<dc:creator>Shoukat Khan</dc:creator>
		<dc:creator>Arwa Salem</dc:creator>
		<dc:creator>Faten Mustafa</dc:creator>
		<dc:creator>Nafiz Hussein</dc:creator>
		<dc:creator>Fasila Pallinalakam</dc:creator>
		<dc:creator>Louisa Grundy</dc:creator>
		<dc:creator>Gemma Patras</dc:creator>
		<dc:creator>Jaishen Rajah</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/3/957">
	<title><![CDATA[Nutrients, Vol. 5, Pages 957-970: Regulatory Effects of Cu, Zn, and Ca on Fe Absorption: The Intricate Play between Nutrient Transporters]]></title>
	<link>http://www.mdpi.com/2072-6643/5/3/957</link>
	<description>Iron is an essential nutrient for almost every living organism because it is required in a number of biological processes that serve to maintain life. In humans, recycling of senescent erythrocytes provides most of the daily requirement of iron. In addition, we need to absorb another 1–2 mg Fe from the diet each day to compensate for losses due to epithelial sloughing, perspiration, and bleeding. Iron absorption in the intestine is mainly regulated on the enterocyte level by effectors in the diet and systemic regulators accessing the enterocyte through the basal lamina. Recently, a complex meshwork of interactions between several trace metals and regulatory proteins was revealed. This review focuses on advances in our understanding of Cu, Zn, and Ca in the regulation of iron absorption. Ascorbate as an important player is also considered.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-03-20</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5030957</prism:doi>
	<prism:startingPage>957</prism:startingPage>
		<prism:endingPage>970</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Regulatory Effects of Cu, Zn, and Ca on Fe Absorption: The Intricate Play between Nutrient Transporters]]></dc:title>
    <dc:date>2013-03-20</dc:date>
	<dc:identifier>doi: 10.3390/nu5030957</dc:identifier>
    	<dc:creator>Nathalie Scheers</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/3/949">
	<title><![CDATA[Nutrients, Vol. 5, Pages 949-956: Vitamin D and Obesity]]></title>
	<link>http://www.mdpi.com/2072-6643/5/3/949</link>
	<description>Obesity is a significant health problem world-wide, particularly in developed nations. Vitamin D deficiency is pandemic, and has been implicated in a wide variety of disease states. This paper seeks to examine the consistently reported relationship between obesity and low vitamin D concentrations, with reference to the possible underlying mechanisms. The possibility that vitamin D may assist in preventing or treating obesity is also examined, and recommendations for future research are made. There is a clear need for adequately-powered, prospective interventions which include baseline measurement of 25D concentrations and involve adequate doses of supplemental vitamin D. Until such studies have been reported, the role of vitamin D supplementation in obesity prevention remains uncertain.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-03-20</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5030949</prism:doi>
	<prism:startingPage>949</prism:startingPage>
		<prism:endingPage>956</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Vitamin D and Obesity]]></dc:title>
    <dc:date>2013-03-20</dc:date>
	<dc:identifier>doi: 10.3390/nu5030949</dc:identifier>
    	<dc:creator>Simon Vanlint</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/3/928">
	<title><![CDATA[Nutrients, Vol. 5, Pages 928-948: Lipoprotein Subfractions in Metabolic Syndrome and Obesity: Clinical Significance and Therapeutic Approaches]]></title>
	<link>http://www.mdpi.com/2072-6643/5/3/928</link>
	<description>Small, dense low density lipoprotein (sdLDL) represents an emerging cardiovascular risk factor, since these particles can be associated with cardiovascular disease (CVD) independently of established risk factors, including plasma lipids. Obese subjects frequently have atherogenic dyslipidaemia, including elevated sdLDL levels, in addition to elevated triglycerides (TG), very low density lipoprotein (VLDL) and apolipoprotein-B, as well as decreased high density lipoprotein cholesterol (HDL-C) levels. Obesity-related co-morbidities, such as metabolic syndrome (MetS) are also characterized by dyslipidaemia. Therefore, agents that favourably modulate LDL subclasses may be of clinical value in these subjects. Statins are the lipid-lowering drug of choice. Also, anti-obesity and lipid lowering drugs other than statins could be useful in these patients. However, the effects of anti-obesity drugs on CVD risk factors remain unclear. We review the clinical significance of sdLDL in being overweight and obesity, as well as the efficacy of anti-obesity drugs on LDL subfractions in these individuals; a short comment on HDL subclasses is also included. Our literature search was based on PubMed and Scopus listings. Further research is required to fully explore both the significance of sdLDL and the efficacy of anti-obesity drugs on LDL subfractions in being overweight, obesity and MetS. Improving the lipoprotein profile in these patients may represent an efficient approach for reducing cardiovascular risk.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-03-18</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5030928</prism:doi>
	<prism:startingPage>928</prism:startingPage>
		<prism:endingPage>948</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Lipoprotein Subfractions in Metabolic Syndrome and Obesity: Clinical Significance and Therapeutic Approaches]]></dc:title>
    <dc:date>2013-03-18</dc:date>
	<dc:identifier>doi: 10.3390/nu5030928</dc:identifier>
    	<dc:creator>Dragana Nikolic</dc:creator>
		<dc:creator>Niki Katsiki</dc:creator>
		<dc:creator>Giuseppe Montalto</dc:creator>
		<dc:creator>Esma Isenovic</dc:creator>
		<dc:creator>Dimitri Mikhailidis</dc:creator>
		<dc:creator>Manfredi Rizzo</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/3/915">
	<title><![CDATA[Nutrients, Vol. 5, Pages 915-927: The ABC of Vitamin D: A Qualitative Study of the Knowledge and Attitudes Regarding Vitamin D Deficiency amongst Selected Population Groups]]></title>
	<link>http://www.mdpi.com/2072-6643/5/3/915</link>
	<description>Objective: In Australia, vitamin D supply in food is limited, and sun exposure is the main source of vitamin D. However skin cancer risk is high, and the need to gain some sun exposure for adequate vitamin D is challenging public health messages to use protection in the sun. The complex vitamin D public health message may be confusing the public and, in particular, those at highest risk for vitamin D deficiency. This study explored vitamin D and sun exposure attitudes, knowledge and practices of some groups considered at risk of vitamin D deficiency and those delivering healthy sun exposure messages to children. Method: 52 adults participated in six focus groups. Results: Results corroborated with previous research showing low levels of vitamin D knowledge. Individual and environmental barriers to receiving adequate sun exposure were also identified. Conclusions and Implications: The message advocating balanced sun exposure to produce adequate vitamin D needs to be made clearer and be more effectively communicated. Findings provide insights to aid development of appropriate public health messages for safe sun exposure and vitamin D, especially for vulnerable groups.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-03-15</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5030915</prism:doi>
	<prism:startingPage>915</prism:startingPage>
		<prism:endingPage>927</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[The ABC of Vitamin D: A Qualitative Study of the Knowledge and Attitudes Regarding Vitamin D Deficiency amongst Selected Population Groups]]></dc:title>
    <dc:date>2013-03-15</dc:date>
	<dc:identifier>doi: 10.3390/nu5030915</dc:identifier>
    	<dc:creator>Billie Bonevski</dc:creator>
		<dc:creator>Jamie Bryant</dc:creator>
		<dc:creator>Sylvie Lambert</dc:creator>
		<dc:creator>Irena Brozek</dc:creator>
		<dc:creator>Vanessa Rock</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/3/887">
	<title><![CDATA[Nutrients, Vol. 5, Pages 887-914: Genomic and Epigenomic Insights into Nutrition and  Brain Disorders]]></title>
	<link>http://www.mdpi.com/2072-6643/5/3/887</link>
	<description>Considerable evidence links many neuropsychiatric, neurodevelopmental and neurodegenerative disorders with multiple complex interactions between genetics and environmental factors such as nutrition. Mental health problems, autism, eating disorders, Alzheimer’s disease, schizophrenia, Parkinson’s disease and brain tumours are related to individual variability in numerous protein-coding and non-coding regions of the genome. However, genotype does not necessarily determine neurological phenotype because the epigenome modulates gene expression in response to endogenous and exogenous regulators, throughout the life-cycle. Studies using both genome-wide analysis of multiple genes and comprehensive analysis of specific genes are providing new insights into genetic and epigenetic mechanisms underlying nutrition and neuroscience. This review provides a critical evaluation of the following related areas: (1) recent advances in genomic and epigenomic technologies, and their relevance to brain disorders; (2) the emerging  role of non-coding RNAs as key regulators of transcription, epigenetic processes  and gene silencing; (3) novel approaches to nutrition, epigenetics and neuroscience;  (4) gene-environment interactions, especially in the serotonergic system, as a paradigm of the multiple signalling pathways affected in neuropsychiatric and neurological disorders. Current and future advances in these four areas should contribute significantly to the prevention, amelioration and treatment of multiple devastating brain disorders.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-03-15</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5030887</prism:doi>
	<prism:startingPage>887</prism:startingPage>
		<prism:endingPage>914</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Genomic and Epigenomic Insights into Nutrition and  Brain Disorders]]></dc:title>
    <dc:date>2013-03-15</dc:date>
	<dc:identifier>doi: 10.3390/nu5030887</dc:identifier>
    	<dc:creator>Margaret Dauncey</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/3/877">
	<title><![CDATA[Nutrients, Vol. 5, Pages 877-886: Pathology of Bursae of Fabricius in Methionine-Deficient  Broiler Chickens]]></title>
	<link>http://www.mdpi.com/2072-6643/5/3/877</link>
	<description>The purpose of this 42-day study was to investigate the effects of methionine (Met) deficiency on immune function by determining the relative weight, morphological and ultrastructural changes of bursae of Fabricius, cell cycle, and apoptosis of bursa cells. One hundred and twenty one-day-old avian broilers were randomly divided into two groups and fed on a control diet (starter diet, Met 0.50%; grower diet, Met 0.40%) and Met-deficient diet (starter diet, Met 0.26%; grower diet, Met 0.28%) for six weeks. The relative weight of bursae was decreased with Met deficiency when compared to that of the control group. Lesions were also observed in the Met-deficient group. Histopathologically, the numbers of lymphocytes in the follicles were decreased. Ultrastructurally, the mitochondria of lymphocytes were swollen in the Met-deficient group. As measured by flow cytometry, bursal cells in the G0G1 phase were significantly higher (P &amp;amp;lt; 0.01), and bursal cells in the S, G2M phases and proliferating index were obviously lower (P &amp;amp;lt; 0.01) with Met deficiency than in the control group. Moreover, the percentage of apoptotic cells in the bursae were significantly increased in Met-deficient birds (P &amp;amp;lt; 0.01). It was concluded that Met deficiency restrained the development of the bursae of Fabricius and affected the humoral immunity of the chickens.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-03-13</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5030877</prism:doi>
	<prism:startingPage>877</prism:startingPage>
		<prism:endingPage>886</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Pathology of Bursae of Fabricius in Methionine-Deficient  Broiler Chickens]]></dc:title>
    <dc:date>2013-03-13</dc:date>
	<dc:identifier>doi: 10.3390/nu5030877</dc:identifier>
    	<dc:creator>Bangyuan Wu</dc:creator>
		<dc:creator>Hengmin Cui</dc:creator>
		<dc:creator>Xi Peng</dc:creator>
		<dc:creator>Jing Fang</dc:creator>
		<dc:creator>Wei Cui</dc:creator>
		<dc:creator>Xiaodong Liu</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/3/852">
	<title><![CDATA[Nutrients, Vol. 5, Pages 852-876: Influence of Amino Acids, Dietary Protein, and Physical Activity on Muscle Mass Development in Humans]]></title>
	<link>http://www.mdpi.com/2072-6643/5/3/852</link>
	<description>Ingestion of protein is crucial for maintenance of a variety of body functions and within the scope of this review we will specifically focus on the regulation of skeletal muscle mass. A quantitative limitation exists as to how much muscle protein the body can synthesize in response to protein intake. Ingestion of excess protein exerts an unwanted load to the body and therefore, it is important to find the least amount of protein that provides the maximal hypertrophic stimulus. Hence, research has focused on revealing the relationship between protein intake (dose) and its resulting stimulation of muscle protein synthesis (response). In addition to the protein amount, the protein digestibility and, hence, the availability of its constituent amino acids is decisive for the response. In this regard, recent studies have provided in-depth knowledge about the time-course of the muscle protein synthetic response dependent on the characteristics of the protein ingested. The effect of protein intake on muscle protein accretion can further be stimulated by prior exercise training. In the ageing population, physical training may counteract the development of “anabolic resistance” and restore the beneficial effect of protein feeding. Presently, our knowledge is based on measures obtained in standardized experimental settings or during long-term intervention periods. However, to improve coherence between these types of data and to further improve our knowledge of the effects of protein ingestion, other investigative approaches than those presently used are requested.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-03-13</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5030852</prism:doi>
	<prism:startingPage>852</prism:startingPage>
		<prism:endingPage>876</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Influence of Amino Acids, Dietary Protein, and Physical Activity on Muscle Mass Development in Humans]]></dc:title>
    <dc:date>2013-03-13</dc:date>
	<dc:identifier>doi: 10.3390/nu5030852</dc:identifier>
    	<dc:creator>Kasper Dideriksen</dc:creator>
		<dc:creator>Søren Reitelseder</dc:creator>
		<dc:creator>Lars Holm</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/3/829">
	<title><![CDATA[Nutrients, Vol. 5, Pages 829-851: The Role of Gut Microbiota on Insulin Resistance]]></title>
	<link>http://www.mdpi.com/2072-6643/5/3/829</link>
	<description>The development of obesity and insulin resistance has been extensively studied in the last decades, but the mechanisms underlying these alterations are still not completely understood. The gut microbiota has been identified as a potential contributor to metabolic diseases. It has been shown that obese individuals present different proportions of bacterial phyla compared with lean individuals, with an increase in Firmicutes and Actinobacteria and a decrease in Bacteroidetes. This alteration seems to interfere with intestinal permeability, increasing the absorption of lipopolysaccharide (LPS), which reaches circulation and initiates activation of Toll-like receptor (TLR) 4 and 2 and LPS receptor CD14, leading to increased activation of inflammatory pathways. With these activations, an impairment of the insulin signaling is observed, with decreased phosphorylation of the insulin receptor, insulin receptor substrate (IRS) and Akt, as well as increased inhibitory serine phosphorylation of IRS-1. Altered proportions of bacterial phyla have also been demonstrated to interfere with host’s biochemical pathways, increasing energy extraction and depot in adipose tissue. Therefore, understanding the mechanisms by which the alteration in the gut microbiota produces different signaling activations and phenotype changes may offer an interesting opportunity for the treatment of obesity and type 2 diabetes.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-03-12</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5030829</prism:doi>
	<prism:startingPage>829</prism:startingPage>
		<prism:endingPage>851</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[The Role of Gut Microbiota on Insulin Resistance]]></dc:title>
    <dc:date>2013-03-12</dc:date>
	<dc:identifier>doi: 10.3390/nu5030829</dc:identifier>
    	<dc:creator>Andrea Caricilli</dc:creator>
		<dc:creator>Mario Saad</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/3/811">
	<title><![CDATA[Nutrients, Vol. 5, Pages 811-828: Assessing Eating Disorder Risk: The Pivotal Role of Achievement Anxiety, Depression and Female Gender in  Non-Clinical Samples]]></title>
	<link>http://www.mdpi.com/2072-6643/5/3/811</link>
	<description>The objective of the present study was to assess factors predicting eating disorder risk in a sample of undergraduate students. A structured questionnaire was employed on a random sample (n = 1865) consisting of the following sections: demographics, SCOFF (Sick, Control, One stone, Fat, Food) questionnaire for screening eating disorders and the Achievement Anxiety Test and the Depression, Anxiety and Stress Scale. The students at risk for eating disorders (SCOFF score ≥2) were 39.7%. Eating disorder risk was more frequent in females, students with divorced parents, students who lived alone, students who were seeking a romantic relationship or were married, students who were at a post-secondary vocational institute/college (private-public) educational level and who were more likely to have marks under merit level. Also, the mean scores for the psychological factors of depression, stress and anxiety were higher in students with eating disorder risk. A logistic regression model was produced depicting that depression, stress, female gender, being married and searching for a romantic relationship were risk factors of having an eating disorder risk. The suggested psychological model examined with structural equation modelling signified the role of academic anxiety as an immediate precursor of general anxiety. Hence, college populations in Greece need organized infrastructures of nutrition health services and campaigns to assist in reducing the risk of eating disorders.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-03-12</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5030811</prism:doi>
	<prism:startingPage>811</prism:startingPage>
		<prism:endingPage>828</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Assessing Eating Disorder Risk: The Pivotal Role of Achievement Anxiety, Depression and Female Gender in  Non-Clinical Samples]]></dc:title>
    <dc:date>2013-03-12</dc:date>
	<dc:identifier>doi: 10.3390/nu5030811</dc:identifier>
    	<dc:creator>Konstantinos Fragkos</dc:creator>
		<dc:creator>Christos Frangos</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/3/788">
	<title><![CDATA[Nutrients, Vol. 5, Pages 788-810: Pharmacokinetics of High-Dose Weekly Oral Vitamin D3 Supplementation during the Third Trimester of Pregnancy in Dhaka, Bangladesh]]></title>
	<link>http://www.mdpi.com/2072-6643/5/3/788</link>
	<description>A pharmacokinetic study was conducted to assess the biochemical  dose-response and tolerability of high-dose prenatal vitamin D3 supplementation in Dhaka, Bangladesh (23°N). Pregnant women at 27–30 weeks gestation (n = 28) were randomized to 70,000 IU once + 35,000 IU/week vitamin D3 (group PH: pregnant, higher dose) or 14,000 IU/week vitamin D3 (PL: pregnant, lower dose) until delivery. A group of  non-pregnant women (n = 16) was similarly administered 70,000 IU once + 35,000 IU/week for 10 weeks (NH: non-pregnant, higher-dose). Rise (∆) in serum 25-hydroxyvitamin D concentration ([25(OH)D]) above baseline was the primary pharmacokinetic outcome. Baseline mean [25(OH)D] were similar in PH and PL (35 nmol/L vs. 31 nmol/L, p = 0.34). A dose-response effect was observed: ∆[25(OH)D] at modeled steady-state was 19 nmol/L (95% CI, 1 to 37) higher in PH vs. PL (p = 0.044). ∆[25(OH)D] at modeled steady-state was lower in PH versus NH but the difference was not significant (−15 nmol/L, 95% CI −34 to 5; p = 0.13). In PH, 100% attained [25(OH)D] ≥ 50 nmol/L and 90% attained [25(OH)D] ≥ 80 nmol/L; in PL, 89% attained [25(OH)D] ≥ 50 nmol/L but 56% attained [25(OH)D] ≥ 80 nmol/L. Cord [25(OH)D] (n = 23) was slightly higher in PH versus PL (117 nmol/L vs. 98 nmol/L; p = 0.07). Vitamin D3 was well tolerated; there were no supplement-related serious adverse clinical events or hypercalcemia. In summary, a regimen of an initial dose of 70,000 IU and 35,000 IU/week vitamin D3 in the third trimester of pregnancy was non-hypercalcemic and attained [25(OH)D] ≥ 80 nmol/L in virtually all mothers and newborns. Further research is required to establish the safety of high-dose vitamin D3 in pregnancy and to determine if supplement-induced [25(OH)D] elevations lead to maternal-infant health benefits.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-03-12</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5030788</prism:doi>
	<prism:startingPage>788</prism:startingPage>
		<prism:endingPage>810</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Pharmacokinetics of High-Dose Weekly Oral Vitamin D3 Supplementation during the Third Trimester of Pregnancy in Dhaka, Bangladesh]]></dc:title>
    <dc:date>2013-03-12</dc:date>
	<dc:identifier>doi: 10.3390/nu5030788</dc:identifier>
    	<dc:creator>Daniel Roth</dc:creator>
		<dc:creator>Abdullah Mahmud</dc:creator>
		<dc:creator>Rubhana Raqib</dc:creator>
		<dc:creator>Evana Akhtar</dc:creator>
		<dc:creator>Robert Black</dc:creator>
		<dc:creator>Abdullah Baqui</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/3/771">
	<title><![CDATA[Nutrients, Vol. 5, Pages 771-787: The Dietary Intake of Wheat and other Cereal Grains and Their Role in Inflammation]]></title>
	<link>http://www.mdpi.com/2072-6643/5/3/771</link>
	<description>Wheat is one of the most consumed cereal grains worldwide and makes up a substantial part of the human diet. Although government-supported dietary guidelines in Europe and the U.S.A advise individuals to eat adequate amounts of (whole) grain products per day, cereal grains contain “anti-nutrients,” such as wheat gluten and wheat lectin, that in humans can elicit dysfunction and disease. In this review we discuss evidence from  in vitro, in vivo and human intervention studies that describe how the consumption of wheat, but also other cereal grains, can contribute to the manifestation of chronic inflammation and autoimmune diseases by increasing intestinal permeability and initiating a pro-inflammatory immune response.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-03-12</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5030771</prism:doi>
	<prism:startingPage>771</prism:startingPage>
		<prism:endingPage>787</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[The Dietary Intake of Wheat and other Cereal Grains and Their Role in Inflammation]]></dc:title>
    <dc:date>2013-03-12</dc:date>
	<dc:identifier>doi: 10.3390/nu5030771</dc:identifier>
    	<dc:creator>Karin de Punder</dc:creator>
		<dc:creator>Leo Pruimboom</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/3/758">
	<title><![CDATA[Nutrients, Vol. 5, Pages 758-770: Is There a Therapeutic Role for Selenium in Alpha-1 Antitrypsin Deficiency?]]></title>
	<link>http://www.mdpi.com/2072-6643/5/3/758</link>
	<description>Selenium is an essential trace mineral of fundamental importance to human health. Much of its beneficial influence is attributed to its presence within selenoproteins, a group of proteins containing the rare amino acid selenocysteine. There are 25 known human selenoproteins including glutathione peroxidases, thioredoxin reductases and selenoproteins. Selenoprotein S (SEPS1) is an endoplasmic reticulum (ER) resident selenoprotein involved in the removal of misfolded proteins from the ER. SEPS1 expression can be induced by ER stress, an event that is associated with conformational disorders and occurs due to accumulation of misfolded proteins within the ER. Alpha-1 antitrypsin (AAT) deficiency, also known as genetic emphysema, is a conformational disorder in which the roles of ER stress, SEPS1 and selenium have been investigated. SEPS1 can relieve ER stress in an in vitro model of AAT deficiency by reducing levels of active ATF6 and inhibiting grp78 promoter- and NFκB activity; some of these effects are enhanced in the presence of selenium supplementation. Other studies examining the molecular mechanisms by which selenium mediates its anti-inflammatory effects have identified a role for prostaglandin 15d-PGJ2 in targeting NFκB and PPARγ. Together these ER stress-relieving and anti-inflammatory properties suggest a therapeutic potential for selenium supplementation in genetic emphysema.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-03-11</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5030758</prism:doi>
	<prism:startingPage>758</prism:startingPage>
		<prism:endingPage>770</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Is There a Therapeutic Role for Selenium in Alpha-1 Antitrypsin Deficiency?]]></dc:title>
    <dc:date>2013-03-11</dc:date>
	<dc:identifier>doi: 10.3390/nu5030758</dc:identifier>
    	<dc:creator>Catherine Greene</dc:creator>
		<dc:creator>Roohi Chhabra</dc:creator>
		<dc:creator>Noel McElvaney</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/3/750">
	<title><![CDATA[Nutrients, Vol. 5, Pages 750-757: The Relationship between Lutein and Zeaxanthin Status and Body Fat]]></title>
	<link>http://www.mdpi.com/2072-6643/5/3/750</link>
	<description>The objective of this project was to investigate the relationships between total and regional distribution of body fat and tissue lutein (L) and zeaxanthin (Z) status. Healthy men and women (N = 100; average age: 22.5 year, average BMI: 23.4 kg/m2) were evaluated. Total body and regional fat mass were assessed by dual-energy X-ray absorptiometry (Hologic Delphi A). Serum LZ was measured using reverse phase  high-performance liquid chromatography, and retinal LZ (referred to as macular pigment optical density; MPOD) was measured using heterochromatic flicker photometry. Body fat percentage (total and regional) was inversely related to MPOD (p &amp;amp;lt; 0.01) but no significant relationship was found for serum LZ. Higher body fat percentage, even within relatively healthy limits, is associated with lower tissue LZ status. The results indicate that adiposity may affect the nutritional state of the retina. Such links may be one of the reasons that obesity promotes age-related degenerative conditions of the retina.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-03-08</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5030750</prism:doi>
	<prism:startingPage>750</prism:startingPage>
		<prism:endingPage>757</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[The Relationship between Lutein and Zeaxanthin Status and Body Fat]]></dc:title>
    <dc:date>2013-03-08</dc:date>
	<dc:identifier>doi: 10.3390/nu5030750</dc:identifier>
    	<dc:creator>Emily Bovier</dc:creator>
		<dc:creator>Richard Lewis</dc:creator>
		<dc:creator>Billy Hammond</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/3/725">
	<title><![CDATA[Nutrients, Vol. 5, Pages 725-749: Selenium for the Prevention of Cutaneous Melanoma]]></title>
	<link>http://www.mdpi.com/2072-6643/5/3/725</link>
	<description>The role of selenium (Se) supplementation in cancer prevention is controversial; effects often depend on the nutritional status of the subject and on the chemical form in which Se is provided. We used a combination of in vitro and in vivo models to study two unique therapeutic windows for intervention in the process of cutaneous melanomagenisis, and to examine the utility of two different chemical forms of Se for prevention and treatment of melanoma. We studied the effects of Se in vitro on UV-induced oxidative stress in melanocytes, and on apoptosis and cell cycle progression in melanoma cells.  In vivo, we used the HGF transgenic mouse model of UV-induced melanoma to demonstrate that topical treatment with l-selenomethionine results in a significant delay in the time required for UV-induced melanoma development, but also increases the rate of growth of those tumors once they appear. In a second mouse model, we found that oral administration of high dose methylseleninic acid significantly decreases the size of human melanoma xenografts. Our findings suggest that modestly elevation of selenium levels in the skin might risk acceleration of growth of incipient tumors. Additionally, certain  Se compounds administered at very high doses could have utility for the treatment of  fully-malignant tumors or prevention of recurrence.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-03-07</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5030725</prism:doi>
	<prism:startingPage>725</prism:startingPage>
		<prism:endingPage>749</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Selenium for the Prevention of Cutaneous Melanoma]]></dc:title>
    <dc:date>2013-03-07</dc:date>
	<dc:identifier>doi: 10.3390/nu5030725</dc:identifier>
    	<dc:creator>Pamela Cassidy</dc:creator>
		<dc:creator>Heidi Fain</dc:creator>
		<dc:creator>James Cassidy</dc:creator>
		<dc:creator>Sally Tran</dc:creator>
		<dc:creator>Philip Moos</dc:creator>
		<dc:creator>Kenneth Boucher</dc:creator>
		<dc:creator>Russell Gerads</dc:creator>
		<dc:creator>Scott Florell</dc:creator>
		<dc:creator>Douglas Grossman</dc:creator>
		<dc:creator>Sancy Leachman</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/3/711">
	<title><![CDATA[Nutrients, Vol. 5, Pages 711-724: Effect of Antioxidants and B-Group Vitamins on Risk of Infections in Patients with Type 2 Diabetes Mellitus]]></title>
	<link>http://www.mdpi.com/2072-6643/5/3/711</link>
	<description>Previous studies have revealed that diabetic patients have a decline in immunity and an increased risk of infections, and this may be associated with poor micronutrient status. The aim of this study was to measure the effect of dietary supplements on risk of infection in patients with type 2 diabetes mellitus. One hundred patients with type 2 diabetes mellitus were randomly assigned to receive an oral dose of daily B-group vitamins and antioxidant vitamins (n = 50) or an identical placebo (n = 50) daily for 90 days. Patients had baseline, three and 12 month assessment for nutritional status, fruits and vegetables intake, physical activity and self-reported infections. Supplementation with antioxidants and B-group vitamins significantly increased the plasma concentration of vitamin E and folate and reduced homocysteine in the intervention group (p-values were 0.006, 0.001 and 0.657, respectively). The number of infections reported by the treatment group after three months of supplements was less than that reported by the placebo group, 9 (27%) vs. 15 (36%) (p = 0.623). Corresponding numbers of infections at 12 months were 25 (67.5%) and 27 (56.3%), respectively (p = 0.488). Up to 90% of the diabetic patients were either overweight or obese with a sedentary life style, and their body weight increased further during three months of follow up. The study showed that multivitamin supplements improved vitamin blood concentrations; however, this did not reduce the number of infections in diabetic patients.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-03-05</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5030711</prism:doi>
	<prism:startingPage>711</prism:startingPage>
		<prism:endingPage>724</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Effect of Antioxidants and B-Group Vitamins on Risk of Infections in Patients with Type 2 Diabetes Mellitus]]></dc:title>
    <dc:date>2013-03-05</dc:date>
	<dc:identifier>doi: 10.3390/nu5030711</dc:identifier>
    	<dc:creator>Salah Gariballa</dc:creator>
		<dc:creator>Bachar Afandi</dc:creator>
		<dc:creator>Mamoon Haltem</dc:creator>
		<dc:creator>Javed Yassin</dc:creator>
		<dc:creator>Awad Alessa</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/3/700">
	<title><![CDATA[Nutrients, Vol. 5, Pages 700-710: Daily Dietary Selenium Intake in a High Selenium Area of Enshi, China]]></title>
	<link>http://www.mdpi.com/2072-6643/5/3/700</link>
	<description>Enshi is a high selenium (Se) region in Hubei, China, where human selenosis was observed between 1958 and 1963. This study investigated the daily dietary Se intake of residents in Shadi, a town located 72 km northeast of Enshi City, to assess the risk of human selenosis in the high Se area. Foods consumed typically by the local residents and their hair samples were analyzed for total Se concentration. Concentrations of Se in different diet categories were as follows: cereals: 0.96 ± 0.90 mg kg−1 DW in rice and  0.43 ± 0.55 mg kg−1 DW in corn; tuber: 0.28 ± 0.56 mg kg−1 in potato and  0.36 ± 0.12 mg kg−1 in sweet potato; vegetables: ranging from 0.23 ± 1.00 mg kg−1 in carrot to 1.57 ± 1.06 mg kg−1 in kidney bean; animal proteins: 1.99 ± 1.11 mg kg−1 in chicken and egg. Based on the food Se concentrations and the daily per-capita consumption, the estimated daily Se intake in Shadi was 550 ± 307 µg per capita. Moreover, the Se concentrations in the hairs of local adult residents were  3.13 ± 1.91 mg kg−1 (n = 122) and 2.21 ± 1.14 mg kg−1 (n = 122) for females and males, respectively, suggesting that females might be exposed to higher levels of Se from daily cooking. Although there was no human selenosis occurrence in recent years, the high level of the daily Se intake suggested that the potential risk of selenosis for local residents, especially females, might be a matter of concern.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-03-05</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5030700</prism:doi>
	<prism:startingPage>700</prism:startingPage>
		<prism:endingPage>710</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Daily Dietary Selenium Intake in a High Selenium Area of Enshi, China]]></dc:title>
    <dc:date>2013-03-05</dc:date>
	<dc:identifier>doi: 10.3390/nu5030700</dc:identifier>
    	<dc:creator>Yang Huang</dc:creator>
		<dc:creator>Quanxin Wang</dc:creator>
		<dc:creator>Jin Gao</dc:creator>
		<dc:creator>Zhiqing Lin</dc:creator>
		<dc:creator>Gary Bañuelos</dc:creator>
		<dc:creator>Linxi Yuan</dc:creator>
		<dc:creator>Xuebin Yin</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/3/679">
	<title><![CDATA[Nutrients, Vol. 5, Pages 679-699: Role of Probiotics in Short Bowel Syndrome in Infants and Children—A Systematic Review]]></title>
	<link>http://www.mdpi.com/2072-6643/5/3/679</link>
	<description>Short bowel syndrome (SBS) is a cause of significant morbidity and mortality  in children. Probiotics, due to their beneficial effects on the gastrointestinal tract  (e.g., improving gut barrier function, motility, facilitation of intestinal adaptation and decreasing pathogen load and inflammation) may have a therapeutic role in the management of SBS. To conduct a systematic review of the current evidence for the effects of probiotic supplementation in children with SBS, the standard Cochrane methodology for systematic reviews was used. The databases, Pubmed, Embase, ACTR, CENTRAL, and the international trial registry, and reference lists of articles were searched for randomised (RCT) or quasi-randomised controlled trials reporting on the use of probiotics in SBS. Our search revealed no RCTs on the use of probiotics in children with SBS. We found one small cross-over RCT (placebo controlled crossover clinical trial), one case control study and nine case reports on the use of probiotics in children with SBS. In the crossover RCT,  there was no consistent effect on intestinal permeability (primary outcome) after supplementation with Lactobacillus rhamnosus (LGG) in nine children with SBS. The case control study (four cases: four controls) reported a trend for increase in height and weight velocity and improvement in non-clinical outcomes, such as gut flora, lymphocyte count and serum prealbumin. Five of the nine case reports showed that children (n = 12) with SBS were benefited (e.g., cessation of diarrhoea, improved faecal flora, weight gain and weaning from parenteral nutrition) by probiotic supplementation. The remaining four reported on the adverse effects, such as Lactobacillus sepsis (n = 3) and d-lactic acidosis  (n = 2). There is insufficient evidence on the effects of probiotics in children with SBS. The safety and efficacy of probiotic supplementation in this high-risk cohort needs to be evaluated in large definitive trials.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-03-05</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5030679</prism:doi>
	<prism:startingPage>679</prism:startingPage>
		<prism:endingPage>699</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Role of Probiotics in Short Bowel Syndrome in Infants and Children—A Systematic Review]]></dc:title>
    <dc:date>2013-03-05</dc:date>
	<dc:identifier>doi: 10.3390/nu5030679</dc:identifier>
    	<dc:creator>Vudum Reddy</dc:creator>
		<dc:creator>Sanjay Patole</dc:creator>
		<dc:creator>Shripada Rao</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/3/663">
	<title><![CDATA[Nutrients, Vol. 5, Pages 663-678: Extracts, Anthocyanins and Procyanidins from  Aronia melanocarpa as Radical Scavengers and  Enzyme Inhibitors]]></title>
	<link>http://www.mdpi.com/2072-6643/5/3/663</link>
	<description>Extracts, subfractions, isolated anthocyanins and isolated procyanidins B2, B5 and C1 from the berries and bark of Aronia melanocarpa were investigated for their antioxidant and enzyme inhibitory activities. Four different bioassays were used, namely scavenging of the diphenylpicrylhydrazyl (DPPH) radical, inhibition of 15-lipoxygenase (15-LO), inhibition of xanthine oxidase (XO) and inhibition of α-glucosidase. Among the anthocyanins, cyanidin 3-arabinoside possessed the strongest and cyanidin 3-xyloside the weakest radical scavenging and enzyme inhibitory activity. These effects seem to be influenced by the sugar units linked to the anthocyanidin. Subfractions enriched in procyanidins were found to be potent α-glucosidase inhibitors; they possessed high radical scavenging properties, strong inhibitory activity towards 15-LO and moderate inhibitory activity towards XO. Trimeric procyanidin C1 showed higher activity in the biological assays compared to the dimeric procyanidins B2 and B5. This study suggests that different polyphenolic compounds of A. melanocarpa can have beneficial effects in reducing blood glucose levels due to inhibition of α-glucosidase and may have a potential to alleviate oxidative stress.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-03-04</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5030663</prism:doi>
	<prism:startingPage>663</prism:startingPage>
		<prism:endingPage>678</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Extracts, Anthocyanins and Procyanidins from  Aronia melanocarpa as Radical Scavengers and  Enzyme Inhibitors]]></dc:title>
    <dc:date>2013-03-04</dc:date>
	<dc:identifier>doi: 10.3390/nu5030663</dc:identifier>
    	<dc:creator>Marie Bräunlich</dc:creator>
		<dc:creator>Rune Slimestad</dc:creator>
		<dc:creator>Helle Wangensteen</dc:creator>
		<dc:creator>Cato Brede</dc:creator>
		<dc:creator>Karl Malterud</dc:creator>
		<dc:creator>Hilde Barsett</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/3/651">
	<title><![CDATA[Nutrients, Vol. 5, Pages 651-662: Gut Microbiota as Potential Therapeutic Target for the Treatment of Cow’s Milk Allergy]]></title>
	<link>http://www.mdpi.com/2072-6643/5/3/651</link>
	<description>Cow’s milk allergy (CMA) continues to be a growing health concern for infants living in Western countries. The long-term prognosis for the majority of affected infants is good, with about 80% naturally acquiring tolerance by the age of four years. However, recent studies suggest that the natural history of CMA is changing, with an increasing persistence until later ages. The pathogenesis of CMA, as well as oral tolerance, is complex and not completely known, although numerous studies implicate gut-associated immunity and enteric microflora, and it has been suggested that an altered composition of intestinal microflora results in an unbalanced local and systemic immune response to food allergens. In addition, there are qualitative and quantitative differences in the composition of gut microbiota between patients affected by CMA and healthy infants. These findings prompt the concept that specific beneficial bacteria from the human intestinal microflora, designated probiotics, could restore intestinal homeostasis and prevent or alleviate allergy, at least in part by interacting with the intestinal immune cells. The aim of this paper is to review what is currently known about the use of probiotics as dietary supplements  in CMA.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-03-01</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5030651</prism:doi>
	<prism:startingPage>651</prism:startingPage>
		<prism:endingPage>662</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Gut Microbiota as Potential Therapeutic Target for the Treatment of Cow’s Milk Allergy]]></dc:title>
    <dc:date>2013-03-01</dc:date>
	<dc:identifier>doi: 10.3390/nu5030651</dc:identifier>
    	<dc:creator>Roberto Canani</dc:creator>
		<dc:creator>Margherita Di Costanzo</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/3/637">
	<title><![CDATA[Nutrients, Vol. 5, Pages 637-650: Naringin Improves Diet-Induced Cardiovascular Dysfunction and Obesity in High Carbohydrate, High Fat Diet-Fed Rats]]></title>
	<link>http://www.mdpi.com/2072-6643/5/3/637</link>
	<description>Obesity, insulin resistance, hypertension and fatty liver, together termed metabolic syndrome, are key risk factors for cardiovascular disease. Chronic feeding of a diet high in saturated fats and simple sugars, such as fructose and glucose, induces these changes in rats. Naturally occurring compounds could be a cost-effective intervention to reverse these changes. Flavonoids are ubiquitous secondary plant metabolites; naringin gives the bitter taste to grapefruit. This study has evaluated the effect of naringin on  diet-induced obesity and cardiovascular dysfunction in high carbohydrate, high fat-fed rats. These rats developed increased body weight, glucose intolerance, increased plasma lipid concentrations, hypertension, left ventricular hypertrophy and fibrosis, liver inflammation and steatosis with compromised mitochondrial respiratory chain activity. Dietary supplementation with naringin (approximately 100 mg/kg/day) improved glucose intolerance and liver mitochondrial dysfunction, lowered plasma lipid concentrations and improved the structure and function of the heart and liver without decreasing total body weight. Naringin normalised systolic blood pressure and improved vascular dysfunction and ventricular diastolic dysfunction in high carbohydrate, high fat-fed rats. These beneficial effects of naringin may be mediated by reduced inflammatory cell infiltration, reduced oxidative stress, lowered plasma lipid concentrations and improved liver mitochondrial function in rats.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-02-27</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5030637</prism:doi>
	<prism:startingPage>637</prism:startingPage>
		<prism:endingPage>650</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Naringin Improves Diet-Induced Cardiovascular Dysfunction and Obesity in High Carbohydrate, High Fat Diet-Fed Rats]]></dc:title>
    <dc:date>2013-02-27</dc:date>
	<dc:identifier>doi: 10.3390/nu5030637</dc:identifier>
    	<dc:creator>Md. Alam</dc:creator>
		<dc:creator>Kathleen Kauter</dc:creator>
		<dc:creator>Lindsay Brown</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/3/624">
	<title><![CDATA[Nutrients, Vol. 5, Pages 624-636: Selenoprotein-Transgenic Chlamydomonas reinhardtii]]></title>
	<link>http://www.mdpi.com/2072-6643/5/3/624</link>
	<description>Selenium (Se) deficiency is associated with the occurrence of many  diseases. However, excessive Se supplementation, especially with  inorganic Se, can result in toxicity. Selenoproteins are the major forms  of Se in vivo to exert its biological function. Expression of  those selenoproteins, especially with the application of a newly  developed system, is thus very important for studying the mechanism of  Se in nutrition. The use of Chlamydomonas reinhardtii (C. reinhardtii)  as a biological vector to express an heterogeneous protein is still at  the initial stages of development. In order to investigate the  possibility of using this system to express selenoproteins, human 15-KDa  selenoprotein (Sep15), a small but widely distributed selenoprotein in  mammals, was chosen for the expression platform test. Apart from the  wild-type human Sep15 gene fragment, two Sep15 recombinants were  constructed containing Sep15 open reading frame (ORF) and the  selenocysteine insertion sequence (SECIS) element from either human  Sep15 or C. reinhardtii selenoprotein W1, a highly expressed selenoprotein in this alga. Those Sep15-containing plasmids were transformed into C. reinhardtii CC-849 cells. Results showed that Sep15 fragments were successfully  inserted into the nuclear genome and expressed Sep15 protein in the  cells. The transgenic and wild-type algae demonstrated similar growth  curves in low Se culture medium. To our knowledge, this is the first  report on expressing human selenoprotein in green alga.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-02-26</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5030624</prism:doi>
	<prism:startingPage>624</prism:startingPage>
		<prism:endingPage>636</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Selenoprotein-Transgenic Chlamydomonas reinhardtii]]></dc:title>
    <dc:date>2013-02-26</dc:date>
	<dc:identifier>doi: 10.3390/nu5030624</dc:identifier>
    	<dc:creator>Qintang Hou</dc:creator>
		<dc:creator>Shi Qiu</dc:creator>
		<dc:creator>Qiong Liu</dc:creator>
		<dc:creator>Jing Tian</dc:creator>
		<dc:creator>Zhangli Hu</dc:creator>
		<dc:creator>Jiazuan Ni</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/2/608">
	<title><![CDATA[Nutrients, Vol. 5, Pages 608-623: Enteral and Parenteral Nutrition in the Perioperative Period: State of the Art]]></title>
	<link>http://www.mdpi.com/2072-6643/5/2/608</link>
	<description>Nutritional support of surgical and critically ill patients has undergone significant advances since 1936 when Studley demonstrated a direct relationship between pre-operative weight loss and operative mortality. The advent of total parenteral nutrition followed by the extraordinary progress in parenteral and enteral feedings, in addition to the increased knowledge of cellular biology and biochemistry, have allowed clinicians to treat malnutrition and improve surgical patient’s outcomes. We reviewed the literature for the current status of perioperative nutrition comparing parenteral nutrition with enteral nutrition. In a surgical patient with established malnutrition, nutritional support should begin at least 7–10 days prior to surgery. Those patients in whom eating is not anticipated beyond the first five days following surgery should receive the benefits of early enteral or parenteral feeding depending on whether the gut can be used. Compared to parenteral nutrition, enteral nutrition is associated with fewer complications, a decrease in the length of hospital stay, and a favorable cost-benefit analysis. In addition, many patients  may benefit from newer enteral formulations such as Immunonutrition as well as  disease-specific formulations.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-02-21</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5020608</prism:doi>
	<prism:startingPage>608</prism:startingPage>
		<prism:endingPage>623</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Enteral and Parenteral Nutrition in the Perioperative Period: State of the Art]]></dc:title>
    <dc:date>2013-02-21</dc:date>
	<dc:identifier>doi: 10.3390/nu5020608</dc:identifier>
    	<dc:creator>Salim Abunnaja</dc:creator>
		<dc:creator>Andrea Cuviello</dc:creator>
		<dc:creator>Juan Sanchez</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/2/594">
	<title><![CDATA[Nutrients, Vol. 5, Pages 594-607: Distribution of Selenium and Oxidative Stress in Breast Tumor-Bearing Mice]]></title>
	<link>http://www.mdpi.com/2072-6643/5/2/594</link>
	<description>The present study investigated the effects of breast tumors on the blood and tissue distribution of essential trace mineral selenium (Se), and oxidative stress status of mice. Female 10-week-old BALB/cByJNarl mice were randomly assigned into control (CNL) and breast tumor-bearing (TB) groups. TB mice were injected subcutaneously into the right hind thigh with 5 × 106 EMT6 mouse mammary tumor cells. After 22 days, we measured Se concentrations, Se-dependent glutathione peroxidase (GPx) activities, and malondialdehyde (MDA) products (indicator of oxidative stress) in plasma, various tissues, and plasma vascular endothelial growth factor (VEGF) concentrations. There were no significant differences in body weights and daily intake between both groups. Compared with the CNL group, TB mice have decreases in plasma Se concentrations and GPx activities, as well as higher plasma VEGF and MDA concentrations. Plasma Se concentrations were also negatively correlated with plasma MDA and VEGF concentrations. Furthermore, tissue Se concentrations and GPx activities in TB animals were lower; whereas the MDA concentrations higher in various tissues including liver, kidney, brain, lung, spleen, and thymic tissues. In conclusion, disruption of Se homeostasis critically reflects oxidative stress in target tissues, thus may increase the risk for progression of breast cancer and metastasis.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-02-20</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5020594</prism:doi>
	<prism:startingPage>594</prism:startingPage>
		<prism:endingPage>607</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Distribution of Selenium and Oxidative Stress in Breast Tumor-Bearing Mice]]></dc:title>
    <dc:date>2013-02-20</dc:date>
	<dc:identifier>doi: 10.3390/nu5020594</dc:identifier>
    	<dc:creator>Chih-Hung Guo</dc:creator>
		<dc:creator>Simon Hsia</dc:creator>
		<dc:creator>Pei-Chung Chen</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/2/579">
	<title><![CDATA[Nutrients, Vol. 5, Pages 579-593: Effect of Malnutrition on the Expression of Cytokines  Involved in Th1 Cell Differentiation]]></title>
	<link>http://www.mdpi.com/2072-6643/5/2/579</link>
	<description>Malnutrition is a common cause of secondary immune deficiency and has been linked to an increased susceptibility to infection in humans. Malnutrition specifically affects T-cell-mediated immune responses. The aim of this study was to assess in lymphocytes from malnourished children the expression levels of IL-12, IL-18 and IL-21, molecules that induce the differentiation of T cells related to the immunological cellular response (Th1 response) and the production of cytokines related to the immunological cellular response (Th1 cytokines). We found that the expression levels of IL-12, IL-18 and IL-21 were significantly diminished in malnourished children compared to well-nourished children and were coincident with lower plasmatic levels of IL-2 and IFN-γ (Th1 cytokines). In this study, we show for the first time that the gene expression and intracellular production of cytokines responsible for Th1 cell differentiation (IL-12, IL-18 and IL-21) are diminished in malnourished children. As expected, this finding was related to lower plasmatic levels of IL-2 and IFN-γ. The decreased expression of Th1 cytokines observed in this study may contribute to the deterioration of the immunological Type 1 (cellular) response. We hypothesize that the decreased production of IL-12, IL-18 and IL-21 in malnourished children contributes to their inability to eradicate infections.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-02-19</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5020579</prism:doi>
	<prism:startingPage>579</prism:startingPage>
		<prism:endingPage>593</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Effect of Malnutrition on the Expression of Cytokines  Involved in Th1 Cell Differentiation]]></dc:title>
    <dc:date>2013-02-19</dc:date>
	<dc:identifier>doi: 10.3390/nu5020579</dc:identifier>
    	<dc:creator>Cristina González-Torres</dc:creator>
		<dc:creator>Haydeé González-Martínez</dc:creator>
		<dc:creator>Angel Miliar</dc:creator>
		<dc:creator>Oralia Nájera</dc:creator>
		<dc:creator>Jaime Graniel</dc:creator>
		<dc:creator>Verónica Firo</dc:creator>
		<dc:creator>Catalina Alvarez</dc:creator>
		<dc:creator>Edmundo Bonilla</dc:creator>
		<dc:creator>Leonor Rodríguez</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/2/565">
	<title><![CDATA[Nutrients, Vol. 5, Pages 565-578: Socioeconomic Status Is Significantly Associated with  the Dietary Intakes of Folate and Depression Scales in  Japanese Workers (J-HOPE Study)]]></title>
	<link>http://www.mdpi.com/2072-6643/5/2/565</link>
	<description>The association of socioeconomic status (SES) with nutrient intake attracts public attention worldwide. In the current study, we examined the associations of SES with dietary intake of folate and health outcomes in general Japanese workers. This Japanese occupational cohort consisted off 2266 workers. SES was assessed by a self-administered questionnaire. Intakes of all nutrients were assessed with a validated, brief and self-administered diet history questionnaire (BDHQ). The degree of depressive symptoms was measured by the validated Japanese version of the K6 scale. Multiple linear regression and stratified analysis were used to evaluate the associations of intake with the confounding factors. Path analysis was conducted to describe the impacts of intake on health outcomes. Education levels and household incomes were significantly associated with intake of folate and depression scales (p &amp;amp;lt; 0.05). After adjusting for age, sex and total energy intake, years of education significantly affect the folate intake (β = 0.117, p &amp;amp;lt; 0.001). The structural equation model (SEM) shows that the indirect effect of folate intake is statistically significant and strong (p &amp;amp;lt; 0.05, 56% of direct effect) in the pathway of education level to depression scale. Our study shows both education and income are significantly associated with depression scales in Japanese workers, and the effort to increase the folate intake may alleviate the harms of social disparities on mental health.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-02-18</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5020565</prism:doi>
	<prism:startingPage>565</prism:startingPage>
		<prism:endingPage>578</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Socioeconomic Status Is Significantly Associated with  the Dietary Intakes of Folate and Depression Scales in  Japanese Workers (J-HOPE Study)]]></dc:title>
    <dc:date>2013-02-18</dc:date>
	<dc:identifier>doi: 10.3390/nu5020565</dc:identifier>
    	<dc:creator>Koichi Miyaki</dc:creator>
		<dc:creator>Yixuan Song</dc:creator>
		<dc:creator>Setsuko Taneichi</dc:creator>
		<dc:creator>Akizumi Tsutsumi</dc:creator>
		<dc:creator>Hideki Hashimoto</dc:creator>
		<dc:creator>Norito Kawakami</dc:creator>
		<dc:creator>Masaya Takahashi</dc:creator>
		<dc:creator>Akihito Shimazu</dc:creator>
		<dc:creator>Akiomi Inoue</dc:creator>
		<dc:creator>Sumiko Kurioka</dc:creator>
		<dc:creator>Takuro Shimbo</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/2/552">
	<title><![CDATA[Nutrients, Vol. 5, Pages 552-564: Effects of Dietary Carbohydrate Replaced with Wild Rice (Zizania latifolia (Griseb) Turcz) on Insulin Resistance in Rats Fed with a High-Fat/Cholesterol Diet]]></title>
	<link>http://www.mdpi.com/2072-6643/5/2/552</link>
	<description>Wild rice (WR) is a very nutritious grain that has been used to treat diabetes in Chinese medicinal practice. City diet (CD) is based on the diet consumed by Asian area residents in modern society, which is rich in saturated fats, cholesterol and carbohydrates. The present study was aimed at evaluating the effects of replacing white rice and processed wheat starch of CD with WR as the chief source of dietary carbohydrates on insulin resistance in rats fed with a high-fat/cholesterol diet. Except the rats of the low-fat (LF) diet group, the rats of the other three groups, including to high-fat/cholesterol (HFC) diet, CD and WR diet, were fed with high-fat/cholesterol diets for eight weeks. The rats fed with CD exhibited higher weight gain and lower insulin sensitivity compared to the rats consuming a HFC diet. However, WR suppressed high-fat/cholesterol diet-induced insulin resistance. WR decreased liver homogenate triglyceride and free fatty acids levels, raised serum adiponectin concentration and reduced serum lipocalin-2 and visfatin concentrations. In addition, the WR diet potently augmented the relative expressions of adiponectin receptor 2, peroxisome proliferator-activated receptors, alpha and gamma, and abated relative expressions of leptin and lipocalin-2 in the tissues of interest. These findings indicate that WR is effective in ameliorating abnormal glucose metabolism and insulin resistance in rats, even when the diet consumed is high in fat and cholesterol.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-02-15</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Abstract</prism:section>
	<prism:doi>10.3390/nu5020552</prism:doi>
	<prism:startingPage>552</prism:startingPage>
		<prism:endingPage>564</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Effects of Dietary Carbohydrate Replaced with Wild Rice (Zizania latifolia (Griseb) Turcz) on Insulin Resistance in Rats Fed with a High-Fat/Cholesterol Diet]]></dc:title>
    <dc:date>2013-02-15</dc:date>
	<dc:identifier>doi: 10.3390/nu5020552</dc:identifier>
    	<dc:creator>Shufen Han</dc:creator>
		<dc:creator>Hong Zhang</dc:creator>
		<dc:creator>Liqiang Qin</dc:creator>
		<dc:creator>Chengkai Zhai</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/2/543">
	<title><![CDATA[Nutrients, Vol. 5, Pages 543-551: Effects of Lutein and Docosahexaenoic Acid Supplementation on Macular Pigment Optical Density in a Randomized Controlled Trial]]></title>
	<link>http://www.mdpi.com/2072-6643/5/2/543</link>
	<description>We studied the macular pigment ocular density (MPOD) in patients with early age macular degeneration (AMD) before and 1 year after nutritional supplementation with lutein and docosahexaenoic acid (DHA). Forty-four patients with AMD were randomly divided into two groups that received placebo (n = 21) or a nutritional supplement (n = 23, 12 mg of lutein and  280 mg of DHA daily). Heterochromatic flicker photometry was used to determine the MPOD. At baseline, the MPOD in AMD patients with placebo was 0.286 ± 0.017 meanwhile in AMD patients with supplementation it was 0.291 ± 0.016. One year later, the mean MPOD had increased by 0.059 in the placebo group and by 0.162 in patients receiving lutein and DHA. This difference between groups was significant (p &amp;amp;lt; 0.05). Lutein and DHA supplementation is effective in increasing the MPOD and may aid in prevention of age related macular degeneration.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-02-15</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Brief Report</prism:section>
	<prism:doi>10.3390/nu5020543</prism:doi>
	<prism:startingPage>543</prism:startingPage>
		<prism:endingPage>551</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Effects of Lutein and Docosahexaenoic Acid Supplementation on Macular Pigment Optical Density in a Randomized Controlled Trial]]></dc:title>
    <dc:date>2013-02-15</dc:date>
	<dc:identifier>doi: 10.3390/nu5020543</dc:identifier>
    	<dc:creator>Alfredo García-Layana</dc:creator>
		<dc:creator>Sergio Recalde</dc:creator>
		<dc:creator>Angel Alamán</dc:creator>
		<dc:creator>Patricia Robredo</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/2/525">
	<title><![CDATA[Nutrients, Vol. 5, Pages 525-542: Reduced Glutathione: A Radioprotector or a Modulator of  DNA-Repair Activity?]]></title>
	<link>http://www.mdpi.com/2072-6643/5/2/525</link>
	<description>The tripeptide glutathione (GSH) is the most abundant intracellular nonprotein thiol, and it is involved in many cellular functions including redox-homeostatic buffering. Cellular radiosensitivity has been shown to be inversely correlated to the endogenous level of GSH. On the other hand, controversy is raised with respect to its role in the field of radioprotection since GSH failed to provide consistent protection in several cases. Reports have been published that DNA repair in cells has a dependence on GSH. Subsequently,  S-glutathionylation (forming mixed disulfides with the protein–sulfhydryl groups), a potent mechanism for posttranslational regulation of a variety of regulatory and metabolic proteins when there is a change in the celluar redox status (lower GSH/GSSG ratio), has received increased attention over the last decade. GSH, as a single agent, is found to affect DNA damage and repair, redox regulation and multiple cell signaling pathways. Thus, seemingly, GSH does not only act as a radioprotector against DNA damage induced by  X-rays through glutathionylation, it may also act as a modulator of the DNA-repair activity. Judging by the number of publications within the last six years, it is obvious that the field of protein glutathionylation impinges on many aspects of biology, from regulation of protein function to roles of cell cycle and apoptosis. Aberrant protein glutathionylation and its association with cancer and other diseases is an area of increasing interest.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-02-07</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5020525</prism:doi>
	<prism:startingPage>525</prism:startingPage>
		<prism:endingPage>542</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Reduced Glutathione: A Radioprotector or a Modulator of  DNA-Repair Activity?]]></dc:title>
    <dc:date>2013-02-07</dc:date>
	<dc:identifier>doi: 10.3390/nu5020525</dc:identifier>
    	<dc:creator>Anupam Chatterjee</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/2/509">
	<title><![CDATA[Nutrients, Vol. 5, Pages 509-524: Do Fat Supplements Increase Physical Performance?]]></title>
	<link>http://www.mdpi.com/2072-6643/5/2/509</link>
	<description>Fish oil and conjugated linoleic acid (CLA) belong to a popular class of food supplements known as “fat supplements”, which are claimed to reduce muscle glycogen breakdown, reduce body mass, as well as reduce muscle damage and inflammatory responses. Sport athletes consume fish oil and CLA mainly to increase lean body mass and reduce body fat. Recent evidence indicates that this kind of supplementation may have other side-effects and a new role has been identified in steroidogenensis. Preliminary findings demonstrate that fish oil and CLA may induce a physiological increase in testosterone synthesis. The aim of this review is to describe the effects of fish oil and CLA on physical performance (endurance and resistance exercise), and highlight the new results on the effects on testosterone biosynthesis. In view of these new data, we can hypothesize that fat supplements may improve the anabolic effect of exercise.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-02-07</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5020509</prism:doi>
	<prism:startingPage>509</prism:startingPage>
		<prism:endingPage>524</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Do Fat Supplements Increase Physical Performance?]]></dc:title>
    <dc:date>2013-02-07</dc:date>
	<dc:identifier>doi: 10.3390/nu5020509</dc:identifier>
    	<dc:creator>Filippo Macaluso</dc:creator>
		<dc:creator>Rosario Barone</dc:creator>
		<dc:creator>Patrizia Catanese</dc:creator>
		<dc:creator>Francesco Carini</dc:creator>
		<dc:creator>Luigi Rizzuto</dc:creator>
		<dc:creator>Felicia Farina</dc:creator>
		<dc:creator>Valentina Di Felice</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/2/498">
	<title><![CDATA[Nutrients, Vol. 5, Pages 498-508: Fat Depots, Free Fatty Acids, and Dyslipidemia]]></title>
	<link>http://www.mdpi.com/2072-6643/5/2/498</link>
	<description>Body fat deposition and excess free fatty acid (FFA) metabolism contribute to dyslipidemia and the adverse health consequences of obesity. Individuals with upper body obesity have impaired functioning of adipocytes, the primary fatty acid storage site. Excess visceral fat is strongly associated with impaired suppression of FFA release in response to insulin, as well as with hypertriglyceridemia and low concentrations of high density lipoprotein (HDL) cholesterol. High FFA concentrations can induce insulin resistance in muscle and liver. Furthermore, failure of hyperinsulinemia to normally suppress FFA is associated with impaired carbohydrate oxidation and muscle glucose storage, reduced hepatic insulin clearance and elevated triglycerides. Understanding the impact of body fat distribution on FFA metabolism and dyslipidemia is critical for determining the link between overweight and obesity and cardiovascular disease risk. In the current review, we will explore the relationship between adipose tissue, body fat depots, and FFA metabolism.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-02-07</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5020498</prism:doi>
	<prism:startingPage>498</prism:startingPage>
		<prism:endingPage>508</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Fat Depots, Free Fatty Acids, and Dyslipidemia]]></dc:title>
    <dc:date>2013-02-07</dc:date>
	<dc:identifier>doi: 10.3390/nu5020498</dc:identifier>
    	<dc:creator>Jon Ebbert</dc:creator>
		<dc:creator>Michael Jensen</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/2/478">
	<title><![CDATA[Nutrients, Vol. 5, Pages 478-497: Brain Enhancing Ingredients from Āyurvedic Medicine: Quintessential Example of Bacopa monniera,  a Narrative Review]]></title>
	<link>http://www.mdpi.com/2072-6643/5/2/478</link>
	<description>Āyurveda, the science (ved) of life (ayu), owing its origin to Veda, the oldest recorded wisdom of human civilization written in 3500 BCE, contains extensive knowledge of various diseases and their therapeutic approaches. It essentially relied on nature and the immune system of an individual, and therapeutic interventions were introduced only to augment the immune system. Āyurveda had eight specialties, including psycho-neuroscience (a combination of psychology, clinical psychology and psychiatry) and a unique promotive therapy encompassing nutrition, rejuvenation and geriatrics. The symptoms of various brain disorders, including memory disorder, were well defined. The goal of Āyurveda was to help an individual to achieve his cherished goal of leading a healthy life of 100 years. To achieve this, great emphasis was laid on nutrition, diet and a good conduct by the two great exponents of Āyurveda viz. Carak and Suśruta. By following these regimens, an individual could lead a less stressful life free from emotional disturbances. Both Carak and Suśruta had believed that these in combination with rasayana (rejuvenating) plants could enable an individual to lead a healthy life of 100 years.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-02-06</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5020478</prism:doi>
	<prism:startingPage>478</prism:startingPage>
		<prism:endingPage>497</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Brain Enhancing Ingredients from Āyurvedic Medicine: Quintessential Example of Bacopa monniera,  a Narrative Review]]></dc:title>
    <dc:date>2013-02-06</dc:date>
	<dc:identifier>doi: 10.3390/nu5020478</dc:identifier>
    	<dc:creator>Hemant Singh</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/2/468">
	<title><![CDATA[Nutrients, Vol. 5, Pages 468-477: Effects of Germinated Brown Rice and Its Bioactive Compounds on the Expression of the Peroxisome Proliferator-Activated Receptor Gamma Gene]]></title>
	<link>http://www.mdpi.com/2072-6643/5/2/468</link>
	<description>Dysregulated metabolism is implicated in obesity and other disease conditions like type 2 diabetes mellitus and cardiovascular diseases, which are linked to abnormalities of peroxisome proliferator-activated receptor gamma (PPARγ). PPARγ has been the focus of much research aimed at managing these diseases. Also, germinated brown rice (GBR) is known to possess antidiabetic, antiobesity and hypocholesterolemic effects. We hypothesized that GBR bioactive compounds may mediate some of the improvements in metabolic indices through PPARγ modulation. Cultured HEP-G2 cells were treated with  50 ppm and 100 ppm of extracts from GBR (GABA, ASG and oryzanol) after determination of cell viabilities using MTT assays. Results showed that all extracts upregulated the expression of the PPARγ. However, combination of all three extracts showed downregulation of the gene, suggesting that, in combination, the effects of these bioactives differ from their individual effects likely mediated through competitive inhibition of the gene. Upregulation of the gene may have therapeutic potential in diabetes mellitus and cardiovascular diseases, while its downregulation likely contributes to GBR’s antiobesity effects. These potentials are worth studying further.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-02-06</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5020468</prism:doi>
	<prism:startingPage>468</prism:startingPage>
		<prism:endingPage>477</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Effects of Germinated Brown Rice and Its Bioactive Compounds on the Expression of the Peroxisome Proliferator-Activated Receptor Gamma Gene]]></dc:title>
    <dc:date>2013-02-06</dc:date>
	<dc:identifier>doi: 10.3390/nu5020468</dc:identifier>
    	<dc:creator>Mustapha Imam</dc:creator>
		<dc:creator>Maznah Ismail</dc:creator>
		<dc:creator>Hairuszah Ithnin</dc:creator>
		<dc:creator>Zaki Tubesha</dc:creator>
		<dc:creator>Abdul Omar</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/2/455">
	<title><![CDATA[Nutrients, Vol. 5, Pages 455-467: An Extract from Wax Apple (Syzygium samarangense (Blume) Merrill and Perry) Effects Glycogenesis and Glycolysis Pathways in Tumor Necrosis Factor-α-Treated FL83B  Mouse Hepatocytes]]></title>
	<link>http://www.mdpi.com/2072-6643/5/2/455</link>
	<description>FL83B mouse hepatocytes were treated with tumor necrosis factor-α (TNF-α) to induce insulin resistance to investigate the effect of a wax apple aqueous extract (WAE) in insulin-resistant mouse hepatocytes. The uptake of 2-[N-(7-nitrobenz-2-oxa-1, 3-diazol-4-yl)amino]-2-deoxyglucose (2 NBDG), a fluorescent d-glucose derivative, was performed, and the metabolism of carbohydrates was evaluated by examining the expression of glycogenesis or glycolysis-related proteins in insulin-resistant hepatocytes. The results show that WAE significantly improves the uptake of glucose and enhances glycogen content in insulin-resistant FL83B mouse hepatocytes. The results from Western blot analysis also reveal that WAE increases the expression of glycogen synthase (GS), hexokinase (HXK), glucose-6-phosphate dehydrogenase (G6PD), phosphofructokinase (PFK) and aldolase in TNF-α treated cells, indicating that WAE may ameliorate glucose metabolism by promoting glycogen synthesis and the glycolysis pathways in insulin-resistant FL83B mouse hepatocytes.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-02-06</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5020455</prism:doi>
	<prism:startingPage>455</prism:startingPage>
		<prism:endingPage>467</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[An Extract from Wax Apple (Syzygium samarangense (Blume) Merrill and Perry) Effects Glycogenesis and Glycolysis Pathways in Tumor Necrosis Factor-α-Treated FL83B  Mouse Hepatocytes]]></dc:title>
    <dc:date>2013-02-06</dc:date>
	<dc:identifier>doi: 10.3390/nu5020455</dc:identifier>
    	<dc:creator>Szu-Chuan Shen</dc:creator>
		<dc:creator>Wen-Chang Chang</dc:creator>
		<dc:creator>Chiao-Li Chang</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/2/441">
	<title><![CDATA[Nutrients, Vol. 5, Pages 441-454: Dairy Consumption and the Risk of 15-Year Cardiovascular Disease Mortality in a Cohort of Older Australians]]></title>
	<link>http://www.mdpi.com/2072-6643/5/2/441</link>
	<description>The effects of habitual dairy consumption and the risk of 15-year cardiovascular disease (CVD) mortality in a cohort of older Australians were investigated. Participants  (n = 2900) completed a validated 145-item semi-quantitative food frequency questionnaire. Cox proportional hazards regression models were used to investigate associations between tertiles of the dairy consumption, including low/reduced fat dairy, whole fat dairy and their ratio (ratioLF/WF), and risk of mortality from coronary heart disease (CHD), stroke or combined CVD. There were 548 recorded cases of CVD mortality in this cohort. For total dairy intake, a reduction in risk of CVD was only seen in tertile 2 (adjusted hazard ratio, AHR: 0.71; 95% CI: 0.55–0.93), and for CHD both tertile 2 and tertile 3 were associated with a reduced risk (both with AHR: 0.71). However there were no linear trends between total dairy consumption and any of the three outcomes. There were no associations or trends between low/reduced fat dairy or whole fat dairy consumption, or ratioLF/WF and any of the three outcomes in the fully adjusted model (all p &amp;amp;gt; 0.05). This study found no consistent association between baseline consumption of dairy foods and the risk of CHD, stroke and combined CVD mortality.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-02-06</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5020441</prism:doi>
	<prism:startingPage>441</prism:startingPage>
		<prism:endingPage>454</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Dairy Consumption and the Risk of 15-Year Cardiovascular Disease Mortality in a Cohort of Older Australians]]></dc:title>
    <dc:date>2013-02-06</dc:date>
	<dc:identifier>doi: 10.3390/nu5020441</dc:identifier>
    	<dc:creator>Jimmy Louie</dc:creator>
		<dc:creator>Victoria Flood</dc:creator>
		<dc:creator>George Burlutsky</dc:creator>
		<dc:creator>Anna Rangan</dc:creator>
		<dc:creator>Timothy Gill</dc:creator>
		<dc:creator>Paul Mitchell</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/2/424">
	<title><![CDATA[Nutrients, Vol. 5, Pages 424-440: Risk of Suboptimal Iodine Intake in Pregnant  Norwegian Women]]></title>
	<link>http://www.mdpi.com/2072-6643/5/2/424</link>
	<description>Pregnant women and infants are exceptionally vulnerable to iodine deficiency. The aims of the present study were to estimate iodine intake, to investigate sources of iodine, to identify predictors of low or suboptimal iodine intake (defined as intakes below 100 μg/day and 150 μg/day) in a large population of pregnant Norwegian women and to evaluate iodine status in a sub-population. Iodine intake was calculated based on a validated Food Frequency Questionnaire in the Norwegian Mother and Child Cohort. The median iodine intake was 141 μg/day from food and 166 μg/day from food and supplements. Use of iodine-containing supplements was reported by 31.6%. The main source of iodine from food was dairy products, contributing 67% and 43% in  non-supplement and iodine-supplement users, respectively. Of 61,904 women, 16.1% had iodine intake below 100 μg/day, 42.0% had iodine intake below 150 μg/day and only 21.7% reached the WHO/UNICEF/ICCIDD recommendation of 250 μg/day. Dietary behaviors associated with increased risk of low and suboptimal iodine intake were: no use of iodine-containing supplements and low intake of milk/yogurt, seafood and eggs. The median urinary iodine concentration measured in 119 participants (69 μg/L) confirmed insufficient iodine intake. Public health strategies are needed to improve and secure the iodine status of pregnant women in Norway.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-02-06</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5020424</prism:doi>
	<prism:startingPage>424</prism:startingPage>
		<prism:endingPage>440</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Risk of Suboptimal Iodine Intake in Pregnant  Norwegian Women]]></dc:title>
    <dc:date>2013-02-06</dc:date>
	<dc:identifier>doi: 10.3390/nu5020424</dc:identifier>
    	<dc:creator>Anne Brantsæter</dc:creator>
		<dc:creator>Marianne Abel</dc:creator>
		<dc:creator>Margaretha Haugen</dc:creator>
		<dc:creator>Helle Meltzer</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/2/411">
	<title><![CDATA[Nutrients, Vol. 5, Pages 411-423: Bellagio Report on Healthy Agriculture, Healthy Nutrition, Healthy People]]></title>
	<link>http://www.mdpi.com/2072-6643/5/2/411</link>
	<description>The Bellagio Report on Healthy Agriculture, Healthy Nutrition, Healthy People is the result of the meeting held at the Rockefeller Foundation Bellagio Center in Lake Como, Italy, 29 October–2 November 2012. The meeting was science-based but  policy-oriented. The role and amount of healthy and unhealthy fats, with attention to the relative content of omega-3 and omega-6 fatty acids, sugar, and particularly fructose in foods that may underlie the epidemics of non-communicable diseases (NCD’s) worldwide were extensively discussed. The report concludes that sugar consumption, especially in the form of high energy fructose in soft drinks, poses a major and insidious health threat, especially in children, and most diets, although with regional differences, are deficient in omega-3 fatty acids and too high in omega-6 fatty acids. Gene-nutrient interactions in growth and development and in disease prevention are fundamental to health, therefore regional Centers on Genetics, Nutrition and Fitness for Health should be established worldwide. Heads of state and government must elevate, as a matter of urgency, Nutrition as a national priority, that access to a healthy diet should be considered a human right and that the lead responsibility for Nutrition should be placed in Ministries of Health rather than agriculture so that the health requirements drive agricultural priorities, not vice versa. Nutritional security should be given the same priority as food security.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-02-05</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Meeting Report</prism:section>
	<prism:doi>10.3390/nu5020411</prism:doi>
	<prism:startingPage>411</prism:startingPage>
		<prism:endingPage>423</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Bellagio Report on Healthy Agriculture, Healthy Nutrition, Healthy People]]></dc:title>
    <dc:date>2013-02-05</dc:date>
	<dc:identifier>doi: 10.3390/nu5020411</dc:identifier>
    	<dc:creator>Artemis Simopoulos</dc:creator>
		<dc:creator>Peter Bourne</dc:creator>
		<dc:creator>Ole Faergeman</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/2/396">
	<title><![CDATA[Nutrients, Vol. 5, Pages 396-410: Soluble Fiber Dextrin and Soluble Corn Fiber Supplementation Modify Indices of Health in Cecum and Colon of  Sprague-Dawley Rats]]></title>
	<link>http://www.mdpi.com/2072-6643/5/2/396</link>
	<description>The objective of this study was to evaluate health outcomes resulting from dietary supplementation of novel, low-digestible carbohydrates in the cecum and colon of Sprague-Dawley rats randomly assigned to one of four treatment groups for 21 days:  5% cellulose (Control), Pectin, soluble fiber dextrin (SFD), or soluble corn fiber (SCF). Rats fed Pectin had a higher average daily food intake, but no differences in final body weights or rates of weight gain among treatments were observed. No differences were observed in total short-chain fatty acid (SCFA) or branched-chain fatty acid (BCFA) concentrations in the cecum and colon of rats fed either SFD or SCF. The SFD and SCF treatments increased cecal propionate and decreased butyrate concentrations compared to Control or Pectin. Pectin resulted in increased BCFA in the cecum and colon. Supplementation of SFD and SCF had no effect on cecal microbial populations compared to Control. Consumption of SFD and SCF increased total and empty cecal weight but not colon weight. Gut histomorphology was positively affected by SFD and SCF. Increased crypt depth, goblet cell numbers, and acidic mucin were observed in both the cecum and colon of rats supplemented with SFD, SCF, and Pectin. These novel, low-digestible carbohydrates appear to be beneficial in modulating indices of hindgut morphology when supplemented in the diet of the rat.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-02-04</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5020396</prism:doi>
	<prism:startingPage>396</prism:startingPage>
		<prism:endingPage>410</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Soluble Fiber Dextrin and Soluble Corn Fiber Supplementation Modify Indices of Health in Cecum and Colon of  Sprague-Dawley Rats]]></dc:title>
    <dc:date>2013-02-04</dc:date>
	<dc:identifier>doi: 10.3390/nu5020396</dc:identifier>
    	<dc:creator>Brenda Knapp</dc:creator>
		<dc:creator>Laura Bauer</dc:creator>
		<dc:creator>Kelly Swanson</dc:creator>
		<dc:creator>Kelly Tappenden</dc:creator>
		<dc:creator>George Fahey</dc:creator>
		<dc:creator>Maria de Godoy</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/2/388">
	<title><![CDATA[Nutrients, Vol. 5, Pages 388-395: Selenium Content in Seafood in Japan]]></title>
	<link>http://www.mdpi.com/2072-6643/5/2/388</link>
	<description>Selenium is an essential micronutrient for humans, and seafood is one of the major selenium sources, as well as red meat, grains, eggs, chicken, liver and garlic. A substantial proportion of the total amount of selenium is present as selenium containing imidazole compound, selenoneine, in the muscles of ocean fish. In order to characterize the selenium content in seafood, the total selenium levels were measured in the edible portions of commercially important fish and shellfish species. Among the tested edible portions, alfonsino muscle had the highest selenium levels (concentration of 1.27 mg/kg tissue). High levels of selenium (1.20–1.07 mg/kg) were also found in the salted ovary products of mullet and Pacific herring. In other fish muscles, the selenium levels ranged between  0.12 and 0.77 mg/kg tissue. The selenium levels were closely correlated with the mercury levels in the white and red muscles in alfonsino. The selenium content in spleen, blood, hepatopancreas, heart, red muscle, white muscle, brain, ovary and testis ranged between 1.10 and 24.8 mg/kg tissue in alfonsino.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-01-31</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5020388</prism:doi>
	<prism:startingPage>388</prism:startingPage>
		<prism:endingPage>395</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Selenium Content in Seafood in Japan]]></dc:title>
    <dc:date>2013-01-31</dc:date>
	<dc:identifier>doi: 10.3390/nu5020388</dc:identifier>
    	<dc:creator>Yumiko Yamashita</dc:creator>
		<dc:creator>Michiaki Yamashita</dc:creator>
		<dc:creator>Haruka Iida</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/2/359">
	<title><![CDATA[Nutrients, Vol. 5, Pages 359-387: Plant Sterols as Anticancer Nutrients: Evidence for Their Role in Breast Cancer]]></title>
	<link>http://www.mdpi.com/2072-6643/5/2/359</link>
	<description>While many factors are involved in the etiology of cancer, it has been clearly established that diet significantly impacts one’s risk for this disease. More recently, specific food components have been identified which are uniquely beneficial in mitigating the risk of specific cancer subtypes. Plant sterols are well known for their effects on blood cholesterol levels, however research into their potential role in mitigating cancer risk remains in its infancy. As outlined in this review, the cholesterol modulating actions of plant sterols may overlap with their anti-cancer actions. Breast cancer is the most common malignancy affecting women and there remains a need for effective adjuvant therapies for this disease, for which plant sterols may play a distinctive role.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-01-31</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5020359</prism:doi>
	<prism:startingPage>359</prism:startingPage>
		<prism:endingPage>387</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Plant Sterols as Anticancer Nutrients: Evidence for Their Role in Breast Cancer]]></dc:title>
    <dc:date>2013-01-31</dc:date>
	<dc:identifier>doi: 10.3390/nu5020359</dc:identifier>
    	<dc:creator>Bruce Grattan</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/2/340">
	<title><![CDATA[Nutrients, Vol. 5, Pages 340-358: Selenistasis: Epistatic Effects of Selenium on  Cardiovascular Phenotype]]></title>
	<link>http://www.mdpi.com/2072-6643/5/2/340</link>
	<description>Although selenium metabolism is intricately linked to cardiovascular biology and function, and deficiency of selenium is associated with cardiac pathology, utilization of selenium in the prevention and treatment of cardiovascular disease remains an elusive goal. From a reductionist standpoint, the major function of selenium in vivo is antioxidant defense via its incorporation as selenocysteine into enzyme families such as glutathione peroxidases and thioredoxin reductases. In addition, selenium compounds are heterogeneous and have complex metabolic fates resulting in effects that are not entirely dependent on selenoprotein expression. This complex biology of selenium in vivo may underlie the fact that beneficial effects of selenium supplementation demonstrated in preclinical studies using models of oxidant stress-induced cardiovascular dysfunction, such as ischemia-reperfusion injury and myocardial infarction, have not been consistently observed in clinical trials. In fact, recent studies have yielded data that suggest that unselective supplementation of selenium may, indeed, be harmful. Interesting biologic actions of selenium are its simultaneous effects on redox balance and methylation status, a combination that may influence gene expression. These combined actions may explain some of the biphasic effects seen with low and high doses of selenium, the potentially harmful effects seen in normal individuals, and the beneficial effects noted in preclinical studies of disease. Given the complexity of selenium biology, systems biology approaches may be necessary to reach the goal of optimization of selenium status to promote health and prevent disease.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-01-31</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5020340</prism:doi>
	<prism:startingPage>340</prism:startingPage>
		<prism:endingPage>358</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Selenistasis: Epistatic Effects of Selenium on  Cardiovascular Phenotype]]></dc:title>
    <dc:date>2013-01-31</dc:date>
	<dc:identifier>doi: 10.3390/nu5020340</dc:identifier>
    	<dc:creator>Jacob Joseph</dc:creator>
		<dc:creator>Joseph Loscalzo</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/2/328">
	<title><![CDATA[Nutrients, Vol. 5, Pages 328-339: Food Safety Attitudes in College Students: A Structural Equation Modeling Analysis of a Conceptual Model]]></title>
	<link>http://www.mdpi.com/2072-6643/5/2/328</link>
	<description>College students are one of the most at-risk population groups for food poisoning, due to risky food safety behaviors. Using the Likert Scale, undergraduate students were asked to participate in a Food Safety Survey which was completed by 499 students ages 18–25. Data was analyzed using SPSS and AMOS statistical software. Four conceptual definitions regarding food safety were defined as: general food safety, bacterial food safety, produce food safety, and politics associated with food safety. Knowledge seems to be an important factor in shaping students attitudes regarding general and bacterial safety. Ethnicity plays a role in how people view the politics of food safety, and the safety of organic foods.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-01-30</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>2</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5020328</prism:doi>
	<prism:startingPage>328</prism:startingPage>
		<prism:endingPage>339</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Food Safety Attitudes in College Students: A Structural Equation Modeling Analysis of a Conceptual Model]]></dc:title>
    <dc:date>2013-01-30</dc:date>
	<dc:identifier>doi: 10.3390/nu5020328</dc:identifier>
    	<dc:creator>Rachelle Booth</dc:creator>
		<dc:creator>Magaly Hernandez</dc:creator>
		<dc:creator>Erica Baker</dc:creator>
		<dc:creator>Tevni Grajales</dc:creator>
		<dc:creator>Peter Pribis</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/1/302">
	<title><![CDATA[Nutrients, Vol. 5, Pages 302-327: Calcium Nutrition and Extracellular Calcium Sensing: Relevance for the Pathogenesis of Osteoporosis, Cancer  and Cardiovascular Diseases]]></title>
	<link>http://www.mdpi.com/2072-6643/5/1/302</link>
	<description>Through a systematic search in Pubmed for literature, on links between calcium malnutrition and risk of chronic diseases, we found the highest degree of evidence for osteoporosis, colorectal and breast cancer, as well as for hypertension, as the only major cardiovascular risk factor. Low calcium intake apparently has some impact also on cardiovascular events and disease outcome. Calcium malnutrition can causally be related to low activity of the extracellular calcium-sensing receptor (CaSR). This member of the family of 7-TM G-protein coupled receptors allows extracellular Ca2+ to function as a “first messenger” for various intracellular signaling cascades. Evidence demonstrates that Ca2+/CaSR signaling in functional linkage with vitamin D receptor (VDR)-activated pathways (i) promotes osteoblast differentiation and formation of mineralized bone;  (ii) targets downstream effectors of the canonical and non-canonical Wnt pathway to inhibit proliferation and induce differentiation of colorectal cancer cells; (iii) evokes Ca2+ influx into breast cancer cells, thereby activating pro-apoptotic intracellular signaling. Furthermore, Ca2+/CaSR signaling opens Ca2+-sensitive K+ conductance channels in vascular endothelial cells, and also participates in IP3-dependent regulation of cytoplasmic Ca2+, the key intermediate of cardiomyocyte functions. Consequently, impairment of Ca2+/CaSR signaling may contribute to inadequate bone formation, tumor progression, hypertension, vascular calcification and, probably, cardiovascular disease.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-01-22</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5010302</prism:doi>
	<prism:startingPage>302</prism:startingPage>
		<prism:endingPage>327</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Calcium Nutrition and Extracellular Calcium Sensing: Relevance for the Pathogenesis of Osteoporosis, Cancer  and Cardiovascular Diseases]]></dc:title>
    <dc:date>2013-01-22</dc:date>
	<dc:identifier>doi: 10.3390/nu5010302</dc:identifier>
    	<dc:creator>Meinrad Peterlik</dc:creator>
		<dc:creator>Enikoe Kállay</dc:creator>
		<dc:creator>Heide Cross</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/1/283">
	<title><![CDATA[Nutrients, Vol. 5, Pages 283-301: Food Sources of Energy and Nutrients among Children in the United States: National Health and Nutrition Examination Survey 2003–2006]]></title>
	<link>http://www.mdpi.com/2072-6643/5/1/283</link>
	<description>Background: Recent detailed analyses of data on dietary sources of energy and nutrients in US children are lacking. The objective of this study was to identify food sources of energy and 28 nutrients for children in the United States. Methods: Analyses of food sources were conducted using a single 24-h recall collected from children 2 to  18 years old (n = 7332) in the 2003–2006 National Health and Nutrition Examination Survey. Sources of nutrients contained in foods were determined using nutrient composition databases. Food grouping included ingredients from disaggregated mixtures. Mean energy and nutrient intakes from the total diet and from each food group were adjusted for the sample design using appropriate weights. Percentages of the total dietary intake that food sources contributed were tabulated by rank order. Results: The two top ranked food/food group sources of energy and nutrients were: energy — milk (7% of energy) and cake/cookies/quick bread/pastry/pie (7%); protein — milk (13.2%) and poultry (12.8%); total carbohydrate — soft drinks/soda (10.5%) and yeast bread/rolls (9.1%); total sugars — soft drinks/soda (19.2%) and yeast breads and rolls (12.7%); added sugars — soft drinks/soda (29.7%) and candy/sugar/sugary foods (18.6%); dietary fiber — fruit (10.4%) and yeast bread/rolls (10.3%); total fat — cheese (9.3%) and crackers/popcorn/pretzels/chips (8.4%); saturated fatty acids — cheese (16.3%) and milk (13.3%); cholesterol — eggs (24.2%) and poultry (13.2%); vitamin D — milk (60.4%) and milk drinks (8.3%); calcium — milk (33.2%) and cheese (19.4%); potassium — milk (18.8%) and fruit juice (8.0%); and sodium — salt (18.5%) and yeast bread and rolls (8.4%). Conclusions: Results suggest that many foods/food groupings consumed by children were energy dense, nutrient poor. Awareness of dietary sources of energy and nutrients can help health professionals design effective strategies to reduce energy consumption and increase the nutrient density of children’s diets.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-01-22</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5010283</prism:doi>
	<prism:startingPage>283</prism:startingPage>
		<prism:endingPage>301</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Food Sources of Energy and Nutrients among Children in the United States: National Health and Nutrition Examination Survey 2003–2006]]></dc:title>
    <dc:date>2013-01-22</dc:date>
	<dc:identifier>doi: 10.3390/nu5010283</dc:identifier>
    	<dc:creator>Debra Keast</dc:creator>
		<dc:creator>Victor Fulgoni</dc:creator>
		<dc:creator>Theresa Nicklas</dc:creator>
		<dc:creator>Carol O&#039;Neil</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/1/267">
	<title><![CDATA[Nutrients, Vol. 5, Pages 267-282: A National Observational Study of the Prevalence and  Use of Enteral Tube Feeding, Parenteral Nutrition and Intravenous Glucose in Cancer Patients Enrolled in Specialized Palliative Care]]></title>
	<link>http://www.mdpi.com/2072-6643/5/1/267</link>
	<description>The use of artificial nutrition remains controversial for cancer patients in palliative care, and its prevalence is largely unknown. We therefore conducted a national study to investigate the prevalence, indications for, and perceived benefit of enteral/parenteral nutrition and intravenous glucose in this patient group. A cross-sectional study was performed within the palliative care research network in Sweden (PANIS), using a web-based survey with 24 questions on demographics, prescribed nutritional treatment, estimated survival and benefit from treatment. Data was received from 32 palliative care units throughout the country, representing 1083 patients with gastrointestinal and gynecological malignancies being the most common diagnoses. Thirteen percent of the patients received enteral/parenteral nutrition or intravenous glucose. Parenteral nutrition (PN) was significantly more common in home care units serving the urban Stockholm region (11%) than in other parts of the country (4%). Weight and appetite loss were the predominant indications for PN, with this treatment deemed beneficial for 75% of the palliative patients. Data show that there was great variation in PN use within the country. PN was predominately initiated when patients had weight and appetite loss but still had oral intake, indicating a use of PN that extends beyond the traditional use for patients with obstruction/semi obstruction.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-01-22</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5010267</prism:doi>
	<prism:startingPage>267</prism:startingPage>
		<prism:endingPage>282</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[A National Observational Study of the Prevalence and  Use of Enteral Tube Feeding, Parenteral Nutrition and Intravenous Glucose in Cancer Patients Enrolled in Specialized Palliative Care]]></dc:title>
    <dc:date>2013-01-22</dc:date>
	<dc:identifier>doi: 10.3390/nu5010267</dc:identifier>
    	<dc:creator>Ylva Orrevall</dc:creator>
		<dc:creator>Carol Tishelman</dc:creator>
		<dc:creator>Johan Permert</dc:creator>
		<dc:creator>Staffan Lundström</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/1/253">
	<title><![CDATA[Nutrients, Vol. 5, Pages 253-266: Does Milk Cause Constipation? A Crossover Dietary Trial]]></title>
	<link>http://www.mdpi.com/2072-6643/5/1/253</link>
	<description>The aims of this study were to: (1) determine whether replacement of cow’s milk protein with soy resolves Chronic Functional Constipation (CFC); and (2) investigate the effects of cow’s milk β casein A1 and cow’s milk β casein A2 on CFC. Children diagnosed with CFC were recruited to one of two crossover trials: Trial 1 compared the effects of cow’s milk and soy milk; Trial 2 compared the effects of cow’s milk β casein A1 and cow’s milk β casein A2. Resolution of constipation was defined as greater than  eight bowel motions during a two week intervention. Thirteen children (18 to 144 months) participated in Trial 1 (6 boys, 7 girls). Nine participants who completed the soy epoch all experienced resolution (p &amp;amp;lt; 0.05). Thirty-nine children (21 to 144 months) participated in Trial 2 (25 boys, 14 girls). Resolution of constipation was highest during the washout epoch, 81%; followed by cow’s milk β casein A2, 79%; and cow’s milk β casein A1, 57%; however, the proportions did not differ statistically. The results of Trial 1 demonstrate an association between CFC and cow’s milk consumption but Trial 2 failed to show an effect from type of casein. Some other component in cow’s milk common to both A1 and A2 milk may be causing a problem in these susceptible children.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-01-22</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5010253</prism:doi>
	<prism:startingPage>253</prism:startingPage>
		<prism:endingPage>266</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Does Milk Cause Constipation? A Crossover Dietary Trial]]></dc:title>
    <dc:date>2013-01-22</dc:date>
	<dc:identifier>doi: 10.3390/nu5010253</dc:identifier>
    	<dc:creator>Elesa Crowley</dc:creator>
		<dc:creator>Lauren Williams</dc:creator>
		<dc:creator>Tim Roberts</dc:creator>
		<dc:creator>Richard Dunstan</dc:creator>
		<dc:creator>Peter Jones</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/1/234">
	<title><![CDATA[Nutrients, Vol. 5, Pages 234-252: Diet-Microbiota Interactions and Their Implications for  Healthy Living]]></title>
	<link>http://www.mdpi.com/2072-6643/5/1/234</link>
	<description>It is well established that diet influences the health of an individual and that  a diet rich in plant-based foods has many advantages in relation to the health and  well-being of an individual. What has been unclear until recently is the large contribution of the gut microbiota to this effect. As well as providing basic nutritional requirements, the long-term diet of an animal modifies its gut microbiota. In adults, diets that have a high proportion of fruit and vegetables and a low consumption of meat are associated with  a highly diverse microbiota and are defined by a greater abundance of Prevotella compared to Bacteroides, while the reverse is associated with a diet that contains a low proportion of plant-based foods. Furthermore, it is becoming increasingly clear that the effect of the microbial ecology of the gut goes beyond the local gut immune system and is implicated in immune-related disorders, such as IBS, diabetes and inflamm-ageing. In this review, we investigate the evidence that a balanced diet leads to a balanced, diverse microbiota with significant consequences for healthy ageing by focusing on conditions of interest.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-01-17</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5010234</prism:doi>
	<prism:startingPage>234</prism:startingPage>
		<prism:endingPage>252</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Diet-Microbiota Interactions and Their Implications for  Healthy Living]]></dc:title>
    <dc:date>2013-01-17</dc:date>
	<dc:identifier>doi: 10.3390/nu5010234</dc:identifier>
    	<dc:creator>Ian Jeffery</dc:creator>
		<dc:creator>Paul O&#039;Toole</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/1/223">
	<title><![CDATA[Nutrients, Vol. 5, Pages 223-233: Effects of Collagen and Collagen Hydrolysate from Jellyfish Umbrella on Histological and Immunity Changes of Mice Photoaging]]></title>
	<link>http://www.mdpi.com/2072-6643/5/1/223</link>
	<description>Jellyfish collagen (JC) was extracted from jellyfish umbrella and hydrolyzed to prepare jellyfish collagen hydrolysate (JCH). The effects of JC and JCH on UV-induced skin damage of mice were evaluated by the skin moisture, microscopic analyses of skin and immunity indexes. The skin moisture analyses showed that moisture retention ability of UV-induced mice skin was increased by JC and JCH. Further histological analysis showed that JC and JCH could repair the endogenous collagen and elastin protein fibers, and could maintain the natural ratio of type I to type III collagen. The immunity indexes showed that JC and JCH play a role in enhancing immunity of photoaging mice in vivo. JCH showed much higher protective ability than JC. These results suggest that JCH as a potential novel antiphotoaging agent from natural resources.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-01-17</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5010223</prism:doi>
	<prism:startingPage>223</prism:startingPage>
		<prism:endingPage>233</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Effects of Collagen and Collagen Hydrolysate from Jellyfish Umbrella on Histological and Immunity Changes of Mice Photoaging]]></dc:title>
    <dc:date>2013-01-17</dc:date>
	<dc:identifier>doi: 10.3390/nu5010223</dc:identifier>
    	<dc:creator>Jian Fan</dc:creator>
		<dc:creator>Yongliang Zhuang</dc:creator>
		<dc:creator>Bafang Li</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/1/208">
	<title><![CDATA[Nutrients, Vol. 5, Pages 208-222: Trust Your Gut: Galvanizing Nutritional Interest in  Intestinal Cholesterol Metabolism for Protection Against  Cardiovascular Diseases]]></title>
	<link>http://www.mdpi.com/2072-6643/5/1/208</link>
	<description>Recent studies have demonstrated that the intestine is a key target organ for overall health and longevity. Complementing these studies is the discovery of the  trans-intestinal cholesterol efflux pathway and the emerging role of the intestine in reverse cholesterol transport. The surfacing dynamics of the regulation of cholesterol metabolism in the intestine provides an attractive platform for intestine-specific nutritional intervention strategies to lower blood cholesterol levels for protection against cardiovascular diseases. Notably, there is mounting evidence that stimulation of pathways associated with calorie restriction may have a large effect on the regulation of cholesterol removal by the intestine. However, intestinal energy metabolism, specifically the idiosyncrasies surrounding intestinal responses to energy deprivation, is poorly understood. The goal of this paper is to review recent insights into cholesterol regulation by the intestine and to discuss the potential for positive regulation of intestine-driven cholesterol removal through the nutritional induction of pathways associated with calorie restriction.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-01-16</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5010208</prism:doi>
	<prism:startingPage>208</prism:startingPage>
		<prism:endingPage>222</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Trust Your Gut: Galvanizing Nutritional Interest in  Intestinal Cholesterol Metabolism for Protection Against  Cardiovascular Diseases]]></dc:title>
    <dc:date>2013-01-16</dc:date>
	<dc:identifier>doi: 10.3390/nu5010208</dc:identifier>
    	<dc:creator>Casey Wegner</dc:creator>
		<dc:creator>Bohkyung Kim</dc:creator>
		<dc:creator>Jiyoung Lee</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/1/162">
	<title><![CDATA[Nutrients, Vol. 5, Pages 162-207: Nutrition of the Critically Ill — A 21st-Century Perspective]]></title>
	<link>http://www.mdpi.com/2072-6643/5/1/162</link>
	<description>Health care-induced diseases constitute a fast-increasing problem. Just one type of these health care-associated infections (HCAI) constitutes the fourth leading cause of death in Western countries. About 25 million individuals worldwide are estimated each year to undergo major surgery, of which approximately 3 million will never return home from the hospital. Furthermore, the quality of life is reported to be significantly impaired for the rest of the lives of those who, during their hospital stay, suffered  life-threatening infections/sepsis. Severe infections are strongly associated with a high degree of systemic inflammation in the body, and intimately associated with significantly reduced and malfunctioning GI microbiota, a condition called dysbiosis. Deranged composition and function of the gastrointestinal microbiota, occurring from the mouth to the anus, has been found to cause impaired ability to maintain intact mucosal membrane functions and prevent leakage of toxins — bacterial endotoxins, as well as whole bacteria or debris of bacteria, the DNA of which are commonly found in most cells of the body, often in adipocytes of obese individuals or in arteriosclerotic plaques. Foods rich in proteotoxins such as gluten, casein and zein, and proteins, have been observed to have endotoxin-like effects that can contribute to dysbiosis. About 75% of the food in the Western diet is of limited or no benefit to the microbiota in the lower gut. Most of it, comprised specifically of refined carbohydrates, is already absorbed in the upper part of the GI tract, and what eventually reaches the large intestine is of limited value, as it contains only small amounts of the minerals, vitamins and other nutrients necessary for maintenance of the microbiota. The consequence is that the microbiota of modern humans is greatly reduced, both in terms of numbers and diversity when compared to the diets of our paleolithic forebears and the individuals living a rural lifestyle today. It is the artificial treatment provided in modern medical care — unfortunately often the only alternative provided — which constitute the main contributors to a poor outcome. These treatments include artificial ventilation, artificial nutrition, hygienic measures, use of skin-penetrating devices, tubes and catheters, frequent use of pharmaceuticals; they are all known to severely impair the microbiomes  in various locations of the body, which, to a large extent, are ultimately responsible for a poor outcome. Attempts to reconstitute a normal microbiome by supply of probiotics have often failed as they are almost always undertaken as a complement to — and not as an alternative to — existing treatment schemes, especially those based on antibiotics, but also other pharmaceuticals.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-01-14</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5010162</prism:doi>
	<prism:startingPage>162</prism:startingPage>
		<prism:endingPage>207</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Nutrition of the Critically Ill — A 21st-Century Perspective]]></dc:title>
    <dc:date>2013-01-14</dc:date>
	<dc:identifier>doi: 10.3390/nu5010162</dc:identifier>
    	<dc:creator>Stig Bengmark</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/1/149">
	<title><![CDATA[Nutrients, Vol. 5, Pages 149-161: Evaluation of Antioxidant Potential of “Maltese Mushroom” (Cynomorium coccineum) by Means of Multiple Chemical and Biological Assays]]></title>
	<link>http://www.mdpi.com/2072-6643/5/1/149</link>
	<description>Cynomorium coccineum is an edible, non-photosynthetic plant widespread along the coasts of the Mediterranean Sea. The medicinal properties of Maltese mushroom — one of the oldest vernacular names used to identify this species — have been kept in high regard since ancient times to the present day. We evaluated the antioxidant potential of fresh specimens of C. coccineum picked in Sardinia, Italy. Both aqueous and methanolic extracts were tested by using multiple assay systems (DPPH, FRAP, TEAC, ORAC-PYR). Total phenolics and flavonoids were also determined. Gallic acid and cyanidin 3-O-glucoside were identified as the main constituents and measured. Both extracts showed antioxidant capacities; ORAC-PYR assay gave the highest antioxidant value in both cases. The methanolic extract was further investigated with in vitro biological models of lipid oxidation; it showed a significant activity in preventing cholesterol degradation and exerted protection against Cu2+-mediated degradation of the liposomal unsaturated fatty acids. Results of the present study demonstrate that the extracts of C. coccineum show a significant total antioxidant power and also exert an in vitro protective effect in different bio-assays of oxidative stress. Therefore, Maltese mushroom can be considered a valuable source of antioxidants and phytochemicals useful in the preparation of nutraceuticals and functional foods.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-01-11</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Article</prism:section>
	<prism:doi>10.3390/nu5010149</prism:doi>
	<prism:startingPage>149</prism:startingPage>
		<prism:endingPage>161</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Evaluation of Antioxidant Potential of “Maltese Mushroom” (Cynomorium coccineum) by Means of Multiple Chemical and Biological Assays]]></dc:title>
    <dc:date>2013-01-11</dc:date>
	<dc:identifier>doi: 10.3390/nu5010149</dc:identifier>
    	<dc:creator>Paolo Zucca</dc:creator>
		<dc:creator>Antonella Rosa</dc:creator>
		<dc:creator>Carlo Tuberoso</dc:creator>
		<dc:creator>Alessandra Piras</dc:creator>
		<dc:creator>Andrea Rinaldi</dc:creator>
		<dc:creator>Enrico Sanjust</dc:creator>
		<dc:creator>Maria Dessì</dc:creator>
		<dc:creator>Antonio Rescigno</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
        <item rdf:about="http://www.mdpi.com/2072-6643/5/1/111">
	<title><![CDATA[Nutrients, Vol. 5, Pages 111-148: Vitamin D — Effects on Skeletal and Extraskeletal Health and the Need for Supplementation]]></title>
	<link>http://www.mdpi.com/2072-6643/5/1/111</link>
	<description>Vitamin D, the sunshine vitamin, has received a lot of attention recently as  a result of a meteoric rise in the number of publications showing that vitamin D plays a crucial role in a plethora of physiological functions and associating vitamin D deficiency with many acute and chronic illnesses including disorders of calcium metabolism, autoimmune diseases, some cancers, type 2 diabetes mellitus, cardiovascular disease and infectious diseases. Vitamin D deficiency is now recognized as a global pandemic. The major cause for vitamin D deficiency is the lack of appreciation that sun exposure has been and continues to be the major source of vitamin D for children and adults of all ages. Vitamin D plays a crucial role in the development and maintenance of a healthy skeleton throughout life. There remains some controversy regarding what blood level of  25-hydroxyvitamin D should be attained for both bone health and reducing risk for vitamin D deficiency associated acute and chronic diseases and how much vitamin D  should be supplemented.</description>

	<prism:publicationName>Nutrients</prism:publicationName>
	<prism:publicationDate>2013-01-10</prism:publicationDate>
	<prism:volume>5</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Review</prism:section>
	<prism:doi>10.3390/nu5010111</prism:doi>
	<prism:startingPage>111</prism:startingPage>
		<prism:endingPage>148</prism:endingPage>
		<prism:issn>2072-6643</prism:issn>
	
	<dc:title><![CDATA[Vitamin D — Effects on Skeletal and Extraskeletal Health and the Need for Supplementation]]></dc:title>
    <dc:date>2013-01-10</dc:date>
	<dc:identifier>doi: 10.3390/nu5010111</dc:identifier>
    	<dc:creator>Matthias Wacker</dc:creator>
		<dc:creator>Michael Holick</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
    
<cc:License rdf:about="http://creativecommons.org/licenses/by/3.0/">
	<cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
	<cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
	<cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
</cc:License>

</rdf:RDF>
